https://curecurrent.com/trials/biodistribution-pharmacokinetics-and-safety-of-f-18-thk-5351-pet-in-alzheimer-s-disease-patients-and-healthy-subjects-po-64002https://curecurrent.com/trials/an-extension-study-of-v203-ad-study-to-evaluate-the-safety-tolerability-immunogenicity-and-efficacy-of-ub-311-64003https://curecurrent.com/trials/florbetaben-as-an-amyloid-plaque-marker-in-elderly-patients-with-focal-or-disseminated-superficial-hemosiderosis-64004https://curecurrent.com/trials/reversal-of-cognitive-decline-recode-study-64005https://curecurrent.com/trials/f-18-t807-tau-pet-imaging-of-progressive-posterior-cortical-dysfunction-ind-123119-protocol-e-64006https://curecurrent.com/trials/mr-guided-tdcs-in-alzheimer-s-disease-64007https://curecurrent.com/trials/the-music-sleep-and-dementia-study-64008https://curecurrent.com/trials/illiteracy-and-vulnerability-to-alzheimer-s-disease-evaluation-of-amyloid-pathology-by-pet-imaging-64009https://curecurrent.com/trials/an-extension-study-of-anavex2-73-in-patients-with-mild-to-moderate-alzheimer-s-disease-64010https://curecurrent.com/trials/a-phase-3-12-week-multicenter-randomized-double-blind-placebo-controlled-trial-to-evaluate-the-efficacy-safety-and-toler-64011https://curecurrent.com/trials/effect-of-choline-alphoscerate-on-cognitive-function-in-alzheimer-s-dementia-64012https://curecurrent.com/trials/randomized-controlled-study-evaluating-cere-110-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64013https://curecurrent.com/trials/to-investigate-the-safety-and-tolerability-of-repeated-subcutaneous-injections-of-cad106-in-alzheimer-s-patients-64014https://curecurrent.com/trials/safety-and-tolerability-of-repeated-subcutaneous-injections-of-cad-106-in-mild-alzheimer-s-patients-64015https://curecurrent.com/trials/evaluation-of-18f-pi-2620-as-a-potential-positron-emission-computed-tomography-radioligand-for-imaging-tau-protein-in-th-64016https://curecurrent.com/trials/18f-thk-5351-positron-emission-computed-tomography-study-of-normal-mild-cognitive-impairment-alzheimer-s-disease-and-oth-64017https://curecurrent.com/trials/a-phase-i-18f-thk-5351-positron-emission-tomography-study-in-healthy-subjects-and-alzheimer-s-disease-64018https://curecurrent.com/trials/aggression-prevention-training-for-caregivers-of-persons-with-dementia-apt-64019https://curecurrent.com/trials/mycose-administration-for-healing-alzheimer-neuropathy-mashiane-64020https://curecurrent.com/trials/acceptance-and-commitment-therapy-for-family-caregivers-of-people-with-dementia-64021https://curecurrent.com/trials/a-phase-i-study-for-safety-and-tolerability-of-al002-64022https://curecurrent.com/trials/predictors-for-poststroke-outcomes-tel-aviv-brain-acute-stroke-cohort-acute-stroke-cohort-tabasco-64023https://curecurrent.com/trials/doxycycline-and-tudca-in-patients-with-transthyretin-amyloid-cardiomyopathy-64024https://curecurrent.com/trials/impact-of-hypno-analgesia-on-pain-during-a-lumbar-puncture-for-diagnosis-of-alzheimer-s-disease-64025https://curecurrent.com/trials/clinical-trial-of-the-immunogenicity-safety-and-efficacy-of-the-gam-covid-vac-vaccine-against-covid-19-in-venezuela-64026https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-combined-single-ascending-dose-and-multiple-ascending-dose-study-64027https://curecurrent.com/trials/safety-and-tolerability-study-of-flexible-dosing-of-brexpiprazole-in-the-treatment-of-subjects-with-agitation-associated-64028https://curecurrent.com/trials/a-study-of-pf-04447943-compared-to-placebo-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64029https://curecurrent.com/trials/a-brief-study-to-evaluate-the-safety-tolerability-and-blood-levels-of-multiple-doses-of-pf-044467943-or-placebo-in-combi-64030https://curecurrent.com/trials/telephone-versus-videoconference-communication-for-remote-genetic-disclosure-in-the-apoe4-trial-64031https://curecurrent.com/trials/brain-imaging-study-of-rosiglitazone-efficacy-and-safety-in-alzheimer-s-disease-64032https://curecurrent.com/trials/compensatory-training-to-support-brain-healthy-lifestyle-changes-in-those-at-risk-for-alzheimer-s-disease-64033https://curecurrent.com/trials/study-of-nasal-insulin-to-fight-forgetfulness-long-acting-insulin-detemir-120-days-sl120-64034https://curecurrent.com/trials/natural-history-and-patient-journey-in-dementia-a-nationwide-linked-electronic-health-records-study-of-5-6-million-indiv-64035https://curecurrent.com/trials/rasagiline-rescue-in-alzheimer-s-disease-clinical-trial-64036https://curecurrent.com/trials/z-drugs-for-sleep-disorders-in-alzheimer-s-disease-64037https://curecurrent.com/trials/bi-425809-in-patients-with-cognitive-impairment-due-to-alzheimer-s-disease-64038https://curecurrent.com/trials/tailored-music-therapy-for-dementia-64039https://curecurrent.com/trials/alzheimer-s-and-blood-glucose-levels-64040https://curecurrent.com/trials/cognitive-behavioral-intervention-via-a-smartphone-app-for-depressive-symptoms-in-caregivers-64041https://curecurrent.com/trials/a-study-to-compare-the-pharmacokinetics-of-br4002-and-br4002-1-in-healthy-volunteers-64042https://curecurrent.com/trials/a-study-to-determine-the-signs-and-symptoms-that-impact-daily-life-of-participants-with-irregular-sleep-wake-rhythm-diso-64043https://curecurrent.com/trials/multimodal-biomarkers-for-diagnosis-and-prognosis-in-vci-64044https://curecurrent.com/trials/cholinesterase-inhibitor-discontinuation-64045https://curecurrent.com/trials/metformin-in-amnestic-mild-cognitive-impairment-64046https://curecurrent.com/trials/development-of-an-exergame-for-caregivers-of-individuals-with-alzheimer-s-disease-or-related-dementias-64047https://curecurrent.com/trials/rajavtihi-neuronal-adult-stem-cells-project-64048https://curecurrent.com/trials/single-dose-study-of-alz-801-prototype-tablets-64049https://curecurrent.com/trials/pragmatic-trial-of-video-education-in-nursing-homes-64050https://curecurrent.com/trials/a-positron-emission-tomography-pet-study-to-investigate-the-brain-biodistribution-of-18f-gsk2647544-in-healthy-subjects-64051https://curecurrent.com/trials/intellicare-in-college-students-64052https://curecurrent.com/trials/optimizing-a-smartphone-application-for-individuals-with-eating-disorders-64053https://curecurrent.com/trials/photobiomodulation-for-improving-brain-function-in-dementia-pbm-dementia-64054https://curecurrent.com/trials/a-study-of-bryostatin-in-moderately-severe-to-severe-alzheimer-s-disease-subjects-not-on-memantine-64055https://curecurrent.com/trials/expanded-access-to-provide-suvn-502-for-the-treatment-of-subjects-with-alzheimer-s-disease-64056https://curecurrent.com/trials/arterial-spin-labeling-asl-mri-for-cognitive-decline-64057https://curecurrent.com/trials/bortezomib-and-dexamethasone-followed-by-high-dose-melphalan-and-stem-cell-transplantation-for-primary-al-amyloidosis-64058https://curecurrent.com/trials/flortaucipir-pet-imaging-in-the-preclinical-prodromal-and-dementia-phases-of-alzheimer-s-disease-64059https://curecurrent.com/trials/exploratory-evaluation-of-flortaucipir-injection-in-healthy-volunteers-and-cognitively-impaired-subjects-64060https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-with-h-coil-in-alzheimer-s-disease-64061https://curecurrent.com/trials/analysis-of-18f-av-1451-pet-imaging-in-cognitively-healthy-mci-and-ad-subjects-64062https://curecurrent.com/trials/f-18-t807-pet-positron-emission-tomograph-scan-for-hiv-infected-uninfected-64063https://curecurrent.com/trials/tricaprilin-in-mild-to-moderate-alzheimer-s-disease-64064https://curecurrent.com/trials/comparisons-of-gait-analyses-performance-between-the-gaitrite-walkways-64065https://curecurrent.com/trials/advanced-cognitive-stimulation-therapy-hong-kong-acst-hk-64066https://curecurrent.com/trials/curcumin-and-yoga-therapy-for-those-at-risk-for-alzheimer-s-disease-64067https://curecurrent.com/trials/memory-for-action-in-neurological-patients-64068https://curecurrent.com/trials/improving-beta-2-adrenergic-signaling-in-alzheimer-s-disease-64069https://curecurrent.com/trials/advanced-cognitive-stimulation-therapy-acst-64070https://curecurrent.com/trials/cognitive-impairment-in-ageing-people-64071https://curecurrent.com/trials/lexical-priming-by-music-in-alzheimer-s-disease-and-healthy-aging-64072https://curecurrent.com/trials/tau-imaging-in-professional-fighters-64073https://curecurrent.com/trials/clinical-evaluation-of-flortaucipir-f-18-64074https://curecurrent.com/trials/a-reader-study-to-assess-accuracy-and-reliability-of-flortaucipir-f-18-positron-emission-tomography-pet-scan-interpretat-64075https://curecurrent.com/trials/efficacy-and-safety-of-mmfs-in-early-ad-64076https://curecurrent.com/trials/18f-av-1451-autopsy-study-64077https://curecurrent.com/trials/a-study-of-flortaucipir-pet-in-healthy-volunteers-and-cognitively-impaired-subjects-64078https://curecurrent.com/trials/imaging-characteristics-of-a-follow-up-18f-av-1451-scan-64079https://curecurrent.com/trials/study-of-lm11a-31-bhs-in-mild-moderate-ad-patients-64080https://curecurrent.com/trials/n-3-pufa-for-vascular-cognitive-aging-64081https://curecurrent.com/trials/study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-single-ascending-oral-doses-of-j147-64082https://curecurrent.com/trials/alzheimer-s-family-caregiver-intervention-in-vietnam-64083https://curecurrent.com/trials/advance-dbs-f-in-patients-with-mild-probable-alzheimer-s-disease-64084https://curecurrent.com/trials/evaluation-of-flortaucipir-pet-signal-and-cognitive-change-in-early-alzheimer-s-disease-64085https://curecurrent.com/trials/safety-and-exploratory-efficacy-study-of-neurostem-versus-placebo-in-patients-with-alzheimer-s-disease-64086https://curecurrent.com/trials/i2petpg-imidazoline2-binding-sites-in-a-group-of-participants-diagnosed-with-ad-64087https://curecurrent.com/trials/assessment-of-initial-efficacy-and-safety-of-high-intensity-focused-ultrasound-exablate-4000-type-2-for-blood-brain-barr-64088https://curecurrent.com/trials/low-level-laser-therapy-impact-on-cognitive-function-and-quality-of-life-in-alzheimer-anemic-elderly-patients-64089https://curecurrent.com/trials/studying-the-effects-of-antihypertensives-on-individuals-at-risk-for-alzheimer-s-64090https://curecurrent.com/trials/follow-up-18f-av-1451-scan-in-confirmatory-cohort-subjects-from-study-18f-av-1451-a05-64091https://curecurrent.com/trials/tau-screening-study-in-patients-with-early-symptomatic-ad-64092https://curecurrent.com/trials/tau-screening-study-in-subjects-with-early-symptomatic-ad-64093https://curecurrent.com/trials/single-and-multiple-ascending-dose-study-of-aducanumab-biib037-in-japanese-participants-with-alzheimer-s-disease-64094https://curecurrent.com/trials/augmenting-flortaucipir-dosimetry-estimates-64095https://curecurrent.com/trials/a-first-in-human-study-of-single-and-multiple-doses-of-anle138b-in-healthy-subjects-64096https://curecurrent.com/trials/multiple-dose-study-of-aducanumab-biib037-recombinant-fully-human-anti-a-igg1-mab-in-participants-with-prodromal-or-mild-64097https://curecurrent.com/trials/safety-and-efficacy-study-of-ladostigil-in-mild-to-moderate-probable-alzheimer-s-disease-64098https://curecurrent.com/trials/impact-of-systematic-tracking-of-dementia-cases-on-the-rate-of-hospitalization-in-emergency-care-units-64099https://curecurrent.com/trials/computerized-olfactory-test-alzheimer-disease-mild-stage-64100https://curecurrent.com/trials/alzheimer-s-prevention-through-exercise-64101https://curecurrent.com/trials/brain-sleep-clearance-of-amyloid-beta-peptides-64102https://curecurrent.com/trials/oral-fecal-microbiota-transplant-feasibility-study-in-alzheimer-s-disease-64103https://curecurrent.com/trials/seizure-activity-in-alzheimer-s-disease-64104https://curecurrent.com/trials/sustainable-method-for-alzheimer-s-prediction-64105https://curecurrent.com/trials/control-and-intervention-programme-on-alzheimer-s-disease-risk-factors-64106https://curecurrent.com/trials/sleep-aging-and-risk-for-alzheimer-s-disease-64107https://curecurrent.com/trials/multiregional-rtfmri-neurofeedback-for-the-prevention-of-alzheimer-s-disease-npad-64108https://curecurrent.com/trials/evaluation-and-characterization-of-behavioural-disorders-and-dementias-by-the-behavioural-dysexecutive-syndrome-inventor-64109https://curecurrent.com/trials/deep-brain-stimulation-for-alzheimer-s-disease-64110https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-crenezumab-versus-placebo-in-participants-with-prodromal-to-mild-alzheimer-64111https://curecurrent.com/trials/a-study-of-crenezumab-versus-placebo-to-evaluate-the-efficacy-and-safety-in-participants-with-prodromal-to-mild-alzheime-64112https://curecurrent.com/trials/association-between-cerebral-arterial-vascular-flow-and-sleep-apnea-in-neurodegenerative-alterations-64113https://curecurrent.com/trials/brain-sleep-deprivation-mri-effects-bedtime-64114https://curecurrent.com/trials/olfactory-deficits-and-donepezil-treatment-in-cognitively-impaired-elderly-64115https://curecurrent.com/trials/an-open-label-crenezumab-study-in-participants-with-alzheimer-s-disease-64116https://curecurrent.com/trials/clinical-trial-to-evaluate-the-efficacy-and-safety-of-gv1001-in-alzheimer-patients-64117https://curecurrent.com/trials/a-extension-study-to-evaluate-revusiran-aln-ttrsc-in-patients-with-transthyretin-ttr-cardiac-amyloidosis-64118https://curecurrent.com/trials/study-to-compare-the-pharmacokinetics-of-tricaprilin-formulations-and-a-placebo-on-ketone-body-production-64119https://curecurrent.com/trials/study-to-compare-the-pharmacokinetics-of-daily-administration-of-tricaprilin-on-ketone-body-production-64120https://curecurrent.com/trials/comparing-smartphone-technology-and-a-memory-strategy-on-improving-prospective-memory-in-alzheimer-s-disease-64121https://curecurrent.com/trials/study-evaluating-the-safety-tolerability-and-efficacy-of-lecozotan-sr-in-outpatients-with-alzheimer-s-disease-64122https://curecurrent.com/trials/phase-i-ii-clinical-trial-of-recombinant-novel-coronavirus-vaccine-adenovirus-type-5-vector-in-canada-64123https://curecurrent.com/trials/a-double-blind-placebo-controlled-safety-and-efficacy-study-of-na-831-64124https://curecurrent.com/trials/a-trial-to-support-caregivers-of-patients-with-dementia-in-italy-the-up-tech-project-64125https://curecurrent.com/trials/safety-and-efficacy-of-nabilone-in-alzheimer-s-disease-64126https://curecurrent.com/trials/management-of-dementia-with-olive-oil-leaves-golden-64127https://curecurrent.com/trials/preventing-loss-of-independence-through-exercise-plie-in-persons-with-dementia-64128https://curecurrent.com/trials/racial-variation-in-response-to-music-interventions-for-people-with-alzheimer-s-dementia-64129https://curecurrent.com/trials/a-study-of-ly2599666-in-healthy-participants-and-participants-with-mild-cognitive-impairment-or-alzheimer-s-disease-ad-64130https://curecurrent.com/trials/novel-dementia-biomarkers-64131https://curecurrent.com/trials/a-multidimensional-behavioral-intervention-for-those-at-risk-for-alzheimer-s-dementia-64132https://curecurrent.com/trials/online-training-certification-for-competency-in-dementia-friendly-hospital-care-64133https://curecurrent.com/trials/a-phase-ii-study-of-cpc-201-to-treat-alzheimer-s-disease-type-dementia-64134https://curecurrent.com/trials/effectiveness-of-a-safety-app-to-respond-to-dating-violence-for-college-women-and-their-friends-64135https://curecurrent.com/trials/a-proof-of-concept-study-of-the-prevention-of-mild-cognitive-impairment-and-eventual-alzheimer-s-disease-using-f18-flute-64136https://curecurrent.com/trials/evaluating-cognitive-and-functional-impairment-in-alzheimer-s-dementia-with-a-ketogenic-diet-64137https://curecurrent.com/trials/connectomics-in-psychiatric-classification-64138https://curecurrent.com/trials/multimodal-imaging-in-the-study-of-disorientation-in-the-hospital-64139https://curecurrent.com/trials/effect-of-hearing-loss-and-vestibular-decline-on-cognitive-function-in-older-subjects-64140https://curecurrent.com/trials/monetary-cost-of-alzheimer-s-disease-in-china-64141https://curecurrent.com/trials/effects-of-sulforaphane-in-patients-with-prodromal-to-mild-alzheimer-s-disease-64142https://curecurrent.com/trials/treatment-of-alzheimer-s-and-dementia-with-the-metabolism-infections-nutrition-drug-elimination-mind-protocol-64143https://curecurrent.com/trials/amyloid-plaque-and-tangle-imaging-in-aging-and-dementia-64144https://curecurrent.com/trials/efficacy-of-hypnosis-on-pain-and-anxiety-during-lumbar-puncture-for-etiological-diagnosis-of-cognitive-impairment-64145https://curecurrent.com/trials/a-clinical-study-evaluating-the-efficacy-and-safety-of-rph201-treatment-in-individuals-with-alzheimer-s-disease-with-or-64146https://curecurrent.com/trials/cbt-for-african-americans-with-cognitive-impairment-64147https://curecurrent.com/trials/feasibility-study-of-transcranial-ultrasound-stimulation-on-alzheimer-s-disease-patients-64148https://curecurrent.com/trials/study-evaluating-intepirdine-rvt-101-on-gait-and-balance-in-subjects-with-dementia-64149https://curecurrent.com/trials/effects-of-a-application-flourish-app-in-medical-students-64150https://curecurrent.com/trials/bpdo-1603-intervention-trial-in-patients-with-moderate-to-severe-alzheimer-s-disease-64151https://curecurrent.com/trials/12-month-open-label-extension-study-of-intepirdine-rvt-101-in-subjects-with-alzheimer-s-disease-mindset-extension-64152https://curecurrent.com/trials/evaluation-of-18f-mni-1126-as-an-imaging-marker-for-synaptic-density-loss-64153https://curecurrent.com/trials/a-safety-tolerability-pharmacokinetics-pharmacodynamics-and-preliminary-efficacy-study-of-tpi-287-in-alzheimer-s-disease-64154https://curecurrent.com/trials/intranasal-glulisine-in-amnestic-mild-cognitive-impairment-and-probable-mild-alzheimer-s-disease-64155https://curecurrent.com/trials/a-study-of-pimavanserin-for-the-treatment-of-agitation-and-aggression-in-subjects-with-alzheimer-s-disease-64156https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-of-dkf-310-donepezil-64157https://curecurrent.com/trials/transcranial-pulse-stimulation-tps-for-alzheimer-s-disease-ad-64158https://curecurrent.com/trials/feasibility-and-effects-of-valaciclovir-treatment-in-persons-with-early-alzheimer-s-disease-64159https://curecurrent.com/trials/the-interactive-physical-and-cognitive-exercise-system-64160https://curecurrent.com/trials/fish-oil-brain-delivery-study-64161https://curecurrent.com/trials/european-prevention-of-alzheimer-s-dementia-epad-longitudinal-cohort-study-lcs-64162https://curecurrent.com/trials/therapeutic-efficacy-of-categorical-language-fluency-smartphone-game-application-64163https://curecurrent.com/trials/tau-imaging-in-young-onset-dementia-64164https://curecurrent.com/trials/efficacy-and-safety-of-ad-35-in-treatment-of-subjects-with-mild-to-moderate-alzheimer-s-disease-64165https://curecurrent.com/trials/vestibular-physical-therapy-for-people-with-alzheimer-disease-64166https://curecurrent.com/trials/single-ascending-dose-study-of-biib076-in-healthy-volunteers-and-participants-with-alzheimer-s-disease-64167https://curecurrent.com/trials/a-randomized-sad-and-mad-study-evaluating-the-safety-and-tolerability-of-rph201-in-healthy-subjects-and-in-adults-with-a-64168https://curecurrent.com/trials/evaluate-the-safety-tolerability-immunogenicity-and-efficacy-of-ub-311-in-mild-alzheimer-s-disease-ad-patients-64169https://curecurrent.com/trials/tes-effects-on-associative-memory-performance-64170https://curecurrent.com/trials/alzheimer-s-disease-clinical-investigation-and-neuroimage-studies-including-18f-pm-pbb3-and-18f-florbetapir-av-45-pet-ex-64171https://curecurrent.com/trials/neurofeedback-intervention-for-preclinical-alzheimer-s-disease-64172https://curecurrent.com/trials/delaying-alzheimer-disease-symptoms-with-anti-inflammatory-drugs-64173https://curecurrent.com/trials/the-locus-coeruleus-and-memory-64174https://curecurrent.com/trials/supporting-episodic-memory-with-transcranial-direct-current-stimulation-in-healthy-controls-and-dementia-patients-64175https://curecurrent.com/trials/computerized-cognitive-training-in-the-elderly-64176https://curecurrent.com/trials/eeg-erp-longitudinal-study-in-alzheimer-s-disease-ad-64177https://curecurrent.com/trials/genetic-information-as-a-life-style-change-motivator-64178https://curecurrent.com/trials/study-to-evaluate-dnl747-in-subjects-with-alzheimer-s-disease-64179https://curecurrent.com/trials/transcranial-direct-current-stimulation-for-depression-in-alzheimer-s-disease-patient-preliminary-research-64180https://curecurrent.com/trials/heart-focused-breathing-in-alzheimer-s-disease-caregivers-64181https://curecurrent.com/trials/multicomponent-intervention-in-caregivers-on-quality-of-life-of-people-with-dementia-a-clinical-trial-64182https://curecurrent.com/trials/study-with-lu-af20513-in-patients-with-mild-alzheimer-s-disease-ad-or-mild-cognitive-impairment-mci-due-to-ad-64183https://curecurrent.com/trials/non-pharmacological-intervention-for-preclinical-alzheimer-s-disease-64184https://curecurrent.com/trials/a-long-term-safety-extension-of-studies-abe4869g-and-abe4955g-in-participants-with-mild-to-moderate-alzheimer-s-disease-64185https://curecurrent.com/trials/a-non-therapeutic-feasibility-study-of-the-radioligand-11c-ucb-j-for-imaging-synaptic-density-64186https://curecurrent.com/trials/the-safety-and-scientific-validity-of-low-dose-whole-brain-radiotherapy-in-alzheimer-s-disease-64187https://curecurrent.com/trials/caregiver-study-dr-phillips-64188https://curecurrent.com/trials/transcranial-electromagnetic-treatment-temt-against-alzheimer-s-disease-64189https://curecurrent.com/trials/phase-1-test-retest-evaluation-of-18f-mni-958-pet-64190https://curecurrent.com/trials/evaluation-of-the-effect-of-wismemo-on-alzheimer-s-dementia-patients-64191https://curecurrent.com/trials/dl-3-n-butylphthalide-treatment-in-patients-with-mild-to-moderate-alzheimer-s-disease-already-receiving-donepezil-64192https://curecurrent.com/trials/to-investigate-the-safety-and-tolerability-of-repeated-subcutaneous-injections-of-cad106-in-alzheimer-s-patients-64193https://curecurrent.com/trials/community-based-cohort-of-functional-decline-in-subjective-cognitive-complaint-elderly-64194https://curecurrent.com/trials/safety-and-tolerability-of-repeated-subcutaneous-injections-of-cad106-in-mild-alzheimer-s-patients-64195https://curecurrent.com/trials/tau-tracer-comparison-in-healthy-controls-and-alzheimer-s-disease-patients-64196https://curecurrent.com/trials/study-on-the-effect-of-transcranial-magnetic-stimulation-in-mild-to-moderate-alzheimer-s-disease-64197https://curecurrent.com/trials/conversations-as-a-means-to-delay-the-onset-of-alzheimer-s-disease-64198https://curecurrent.com/trials/the-efficacy-of-traditional-chinese-herbal-medicine-for-alzheimer-s-disease-64199https://curecurrent.com/trials/a-noval-tau-tracer-in-young-onset-dementia-64200https://curecurrent.com/trials/augmenting-specialty-eating-disorder-clinical-treatment-with-a-smartphone-application-64201https://curecurrent.com/trials/isolated-erythrocyte-membrane-susceptibility-to-photo-oxidative-stress-in-alzheimer-s-disease-64202https://curecurrent.com/trials/a-pharmacodynamics-safety-and-pharmacokinetics-study-of-thn201-versus-donepezil-in-healthy-male-volunteers-64203https://curecurrent.com/trials/emotional-regulation-in-patients-with-implanted-automatic-defibrillator-64204https://curecurrent.com/trials/alzheimer-s-disease-potential-benefit-of-isoflavones-64205https://curecurrent.com/trials/investigating-the-clinical-consequences-of-flutemetamol-pet-scanning-64206https://curecurrent.com/trials/pilot-study-about-extra-virgin-olive-oil-coratina-in-mild-cognitive-impairment-and-alzheimer-s-disease-patients-64207https://curecurrent.com/trials/the-effect-of-tes-on-a-cognitive-training-64208https://curecurrent.com/trials/longitudinal-validation-of-a-computerized-cognitive-battery-cognigram-in-the-diagnosis-of-mild-cognitive-impairment-and-64209https://curecurrent.com/trials/the-china-longitudinal-aging-study-of-cognitive-impairment-64210https://curecurrent.com/trials/effects-of-transcranial-direct-current-stimulation-associated-with-cognitive-training-in-alzheimer-s-disease-64211https://curecurrent.com/trials/longitudinal-evaluation-of-18f-gtp1-as-a-pet-radioligand-for-imaging-tau-in-the-brain-of-participants-with-alzheimer-s-d-64212https://curecurrent.com/trials/neurotrack-test-validation-protocol-64213https://curecurrent.com/trials/brain-study-of-patients-with-frontal-lobe-dementia-and-parkinsonian-disorders-64214https://curecurrent.com/trials/early-markers-of-alzheimer-s-disease-structural-and-functional-brain-changes-64215https://curecurrent.com/trials/phase-ii-study-of-intravenous-immunoglobulin-ivig-for-alzheimer-s-disease-64216https://curecurrent.com/trials/pilot-study-to-assess-the-impact-of-a-mobile-health-application-app-on-clinical-outcomes-and-satisfaction-of-older-hiv-i-64217https://curecurrent.com/trials/a-study-of-lanabecestat-ly3314814-in-participants-with-mild-alzheimer-s-disease-dementia-64218https://curecurrent.com/trials/an-efficacy-and-safety-study-of-lanabecestat-ly3314814-in-early-alzheimer-s-disease-64219https://curecurrent.com/trials/a-study-of-lanabecestat-ly3314814-in-early-alzheimer-s-disease-dementia-64220https://curecurrent.com/trials/study-to-evaluate-the-safety-and-tolerability-of-a-new-drug-named-lu-af20513-in-patients-with-mild-alzheimer-s-disease-64221https://curecurrent.com/trials/reference-database-longitudinal-registry-of-the-normal-and-pathological-aging-brain-64222https://curecurrent.com/trials/cancer-distress-coach-mobile-app-trial-64223https://curecurrent.com/trials/modeling-the-relationships-between-functional-connectivity-and-amyloid-deposition-in-alzheimer-s-disease-64224https://curecurrent.com/trials/p-glycoprotein-function-in-brain-diseases-64225https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-safety-and-tolerability-of-lu-af20513-and-the-antibody-response-in-patients-with-alzhe-64226https://curecurrent.com/trials/the-effectiveness-of-global-postural-reeducation-on-alzheimer-disease-patients-64227https://curecurrent.com/trials/multiple-ascending-dose-study-of-alz-801-64228https://curecurrent.com/trials/24-months-safety-and-efficacy-study-of-aadvac1-in-patients-with-mild-alzheimer-s-disease-64229https://curecurrent.com/trials/research-on-aging-project-in-iceland-second-stage-64230https://curecurrent.com/trials/biomarkers-in-neurodegenerative-diseases-64231https://curecurrent.com/trials/elnd005-in-patients-with-mild-to-moderate-alzheimer-s-disease-64232https://curecurrent.com/trials/nuedexta-in-the-treatment-of-pseudobulbar-affect-in-patients-with-alzheimer-s-disease-64233https://curecurrent.com/trials/relationship-between-down-syndrome-ds-and-alzheimer-s-disease-ad-64234https://curecurrent.com/trials/modafinil-treatment-for-sleep-wake-disturbances-in-older-adults-64235https://curecurrent.com/trials/evaluation-of-safety-and-tolerability-of-libella-gene-therapy-for-alzheimer-s-disease-aav-htert-64236https://curecurrent.com/trials/processing-of-music-in-alzheimer-patients-64237https://curecurrent.com/trials/dc-longitudinal-study-on-aging-and-specimen-bank-64238https://curecurrent.com/trials/blood-biomarker-of-alzheimer-s-disease-ad-64239https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-ckd-355-64240https://curecurrent.com/trials/octohydroaminoacridine-succinate-tablet-for-mild-to-moderate-alzheimer-s-disease-64241https://curecurrent.com/trials/validation-and-standardization-of-a-battery-evaluation-of-the-socio-emotional-functions-in-various-neurological-patholog-64242https://curecurrent.com/trials/elnd005-long-term-follow-up-study-in-subjects-with-alzheimer-s-disease-64243https://curecurrent.com/trials/a-36-week-safety-extension-study-of-elnd005-as-a-treatment-for-agitation-and-aggression-in-alzheimer-s-disease-64244https://curecurrent.com/trials/18f-pm-pbb3-pet-study-in-tauopathy-including-alzheimer-s-disease-other-dementias-and-normal-controls-64245https://curecurrent.com/trials/efficacy-and-safety-study-of-elnd005-as-a-treatment-for-agitation-and-aggression-in-alzheimer-s-disease-64246https://curecurrent.com/trials/safety-and-efficacy-of-suvorexant-mk-4305-for-the-treatment-of-insomnia-in-participants-with-alzheimer-s-disease-mk-4305-64247https://curecurrent.com/trials/a-study-of-solanezumab-ly2062430-in-participants-with-prodromal-alzheimer-s-disease-64248https://curecurrent.com/trials/progress-of-mild-alzheimer-s-disease-in-participants-on-solanezumab-versus-placebo-64249https://curecurrent.com/trials/valproic-acid-in-subjects-with-intact-cognition-proof-of-concept-study-64250https://curecurrent.com/trials/modulation-of-micro-rna-pathways-by-gemfibrozil-in-predementia-alzheimer-disease-64251https://curecurrent.com/trials/continued-safety-monitoring-of-solanezumab-ly2062430-in-alzheimer-s-disease-64252https://curecurrent.com/trials/cogilus-remediation-in-alzheimer-patients-cora-64253https://curecurrent.com/trials/feasibility-and-efficacy-of-dietary-interventions-for-older-adults-with-subjective-cognitive-decline-64254https://curecurrent.com/trials/efficacy-of-a-biodanza-program-in-people-with-alzheimer-s-disease-64255https://curecurrent.com/trials/clinical-effect-size-of-an-educational-intervention-in-the-home-and-compliance-on-people-who-suffer-from-stroke-64256https://curecurrent.com/trials/improving-adherence-healthy-lifestyle-with-a-smartphone-application-based-on-adults-with-intellectual-disabilities-64257https://curecurrent.com/trials/deep-brain-stimulation-dbs-for-alzheimer-s-disease-64258https://curecurrent.com/trials/alzheimer-s-caregiver-coping-mental-and-physical-health-64259https://curecurrent.com/trials/personalized-music-therapy-and-agitation-in-dementia-64260https://curecurrent.com/trials/benefits-of-exercise-in-alzheimer-s-disease-64261https://curecurrent.com/trials/reducing-agitation-in-people-with-dementia-the-customized-activity-trial-64262https://curecurrent.com/trials/amyloid-accumulation-after-mild-traumatic-brain-injury-64263https://curecurrent.com/trials/rhapsody-plus-online-counseling-for-family-caregivers-of-patients-with-young-onset-dementia-64264https://curecurrent.com/trials/a-safety-study-of-ly2886721-single-doses-in-healthy-subjects-64265https://curecurrent.com/trials/study-of-patients-hospitalized-in-specialized-cognitive-behavioral-unit-ucc-64266https://curecurrent.com/trials/biomarker-qualification-for-risk-of-mild-cognitive-impairment-mci-due-to-alzheimer-s-disease-ad-and-safety-and-efficacy-64267https://curecurrent.com/trials/dementia-signal-development-study-of-nautilus-neurowave-tm-for-the-detection-of-dementia-64268https://curecurrent.com/trials/predicting-migraine-attacks-based-on-environmental-and-behavioral-changes-as-detected-from-the-smartphone-64269https://curecurrent.com/trials/nextstep-study-to-evaluate-safety-efficacy-tolerability-of-rivastigmine-patch-in-mild-to-moderate-alzheimer-s-patients-64270https://curecurrent.com/trials/brain-vascular-disease-in-aging-and-dementia-64271https://curecurrent.com/trials/safety-tolerability-and-pharmacokinetics-study-of-ndx-1017-64272https://curecurrent.com/trials/cerebral-and-peripheral-perfusion-pilot-study-64273https://curecurrent.com/trials/dietary-treatments-for-cognitive-impairment-in-older-adults-64274https://curecurrent.com/trials/safety-and-clinical-outcomes-with-amniotic-and-umbilical-cord-tissue-therapy-for-numerous-medical-conditions-64275https://curecurrent.com/trials/erinacine-a-enriched-hericium-erinaceus-mycelia-for-improvement-of-recognition-vision-and-functional-mri-alterations-64276https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-for-apathy-in-alzheimer-s-dementia-64277https://curecurrent.com/trials/study-of-dhp1401-in-patients-with-mild-moderate-alzheimer-s-disease-treated-with-donepezil-drama-64278https://curecurrent.com/trials/validation-of-a-smartphone-application-for-the-assessment-of-patients-with-mild-cognitive-impairment-memscreen-64279https://curecurrent.com/trials/multiple-dose-safety-study-of-npt088-in-patients-with-mild-to-moderate-probable-alzheimer-s-disease-64280https://curecurrent.com/trials/a-phase-iia-multi-center-study-of-18f-fdg-pet-safety-and-tolerability-of-azd0530-in-mild-alzheimer-s-disease-64281https://curecurrent.com/trials/p2x7-receptor-inflammation-and-neurodegenerative-diseases-64282https://curecurrent.com/trials/lutein-and-alzheimer-s-disease-study-64283https://curecurrent.com/trials/statin-effects-on-beta-amyloid-and-cerebral-perfusion-in-adults-at-risk-for-alzheimer-s-disease-64284https://curecurrent.com/trials/clinical-efficacy-of-ginkgo-biloba-extract-in-the-treatment-of-alzheimer-s-disease-64285https://curecurrent.com/trials/a-safety-and-tolerability-study-of-gb301-64286https://curecurrent.com/trials/adaptive-cognitive-training-in-healthy-older-adults-64287https://curecurrent.com/trials/a-study-to-evaluate-albumin-and-immunoglobulin-in-alzheimer-s-disease-64288https://curecurrent.com/trials/evaluation-of-an-innovative-information-training-and-social-support-intervention-infosadem-to-principal-caregivers-of-de-64289https://curecurrent.com/trials/endothelial-facilitation-in-alzheimer-s-disease-64290https://curecurrent.com/trials/intervention-to-reduce-sedentary-time-64291https://curecurrent.com/trials/a-study-of-crenezumab-in-participants-with-mild-to-moderate-alzheimer-disease-64292https://curecurrent.com/trials/effects-of-atomoxetine-in-mild-cognitive-impairment-64293https://curecurrent.com/trials/a-safety-study-of-ly2886721-multiple-doses-in-healthy-subjects-64294https://curecurrent.com/trials/a-study-of-ly2886721-in-healthy-participants-and-participants-diagnosed-with-alzheimer-s-disease-64295https://curecurrent.com/trials/biomarkers-in-neural-disorders-64296https://curecurrent.com/trials/the-effects-of-exercise-program-in-alzheimer-s-patients-with-mild-to-moderate-stage-alzheimer-s-disease-64297https://curecurrent.com/trials/reducing-depressive-symptomatology-with-a-smartphone-app-64298https://curecurrent.com/trials/mobile-tablet-education-to-advance-caregiver-health-64299https://curecurrent.com/trials/18f-flutemetamol-and-plaque-vulnerability-64300https://curecurrent.com/trials/modulation-of-cognition-and-brain-connectivity-by-noninvasive-brain-stimulation-in-patients-with-mild-cognitive-impairme-64301https://curecurrent.com/trials/allopregnanolone-for-mild-cognitive-impairment-due-to-alzheimer-s-disease-or-mild-ad-64302https://curecurrent.com/trials/telomerase-activator-and-retinal-amyloid-64303https://curecurrent.com/trials/levetiracetam-for-alzheimer-s-disease-neuropsychiatric-symptoms-related-to-epilepsy-trial-lapse-64304https://curecurrent.com/trials/ad-4833-tomm40-303-extension-study-of-the-safety-and-efficacy-of-pioglitazone-to-slow-cognitive-decline-in-participants-64305https://curecurrent.com/trials/accompanying-alzheimer-caregiver-64306https://curecurrent.com/trials/caring-for-the-caregiver-network-64307https://curecurrent.com/trials/effect-of-ivig-on-cerebral-and-retinal-amyloid-in-mild-cognitive-impairment-due-to-alzheimer-disease-64308https://curecurrent.com/trials/a-pet-study-of-the-effects-of-p38-map-kinase-inhibitor-vx-745-on-amyloid-plaque-load-in-alzheimer-s-disease-ad-64309https://curecurrent.com/trials/alzheimer-biomarkers-on-csf-of-elderly-patients-undergoing-surgery-64310https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-brain-polypeptide-solution-in-mild-alzheimer-s-disease-64311https://curecurrent.com/trials/study-of-tak-071-in-healthy-participants-and-participants-with-mild-cognitive-impairment-mild-alzheimer-disease-and-rela-64312https://curecurrent.com/trials/effect-of-exercise-training-in-alzheimer-s-patients-64313https://curecurrent.com/trials/evaluating-liraglutide-in-alzheimer-s-disease-64314https://curecurrent.com/trials/a-study-of-ly3372993-in-healthy-participants-and-participants-with-alzheimer-s-disease-ad-64315https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-id1201-for-dose-finding-in-mild-alzheimer-s-disease-64316https://curecurrent.com/trials/sad-mad-study-to-assess-safety-tolerability-pk-pd-of-medi1814-in-subjects-with-mild-moderate-alzheimer-s-disease-64317https://curecurrent.com/trials/intensive-instruction-on-the-use-of-aricept-64318https://curecurrent.com/trials/application-of-amyloid-pet-in-cerebral-amyloid-angiopathy-64319https://curecurrent.com/trials/pharmacokinetics-of-tricaprilin-including-food-effect-on-ketone-body-production-64320https://curecurrent.com/trials/mad-phase-i-study-to-investigate-contraloid-acetate-64321https://curecurrent.com/trials/efficacy-and-safety-trial-of-verubecestat-mk-8931-in-participants-with-prodromal-alzheimer-s-disease-mk-8931-019-64322https://curecurrent.com/trials/tele-dermatology-of-skin-cancer-in-a-cohort-of-local-health-authority-employees-in-the-province-of-bergamo-64323https://curecurrent.com/trials/sleep-in-adults-with-down-syndrome-and-alzheimer-s-disease-64324https://curecurrent.com/trials/sad-phase-i-study-first-in-human-to-investigate-contraloid-acetate-64325https://curecurrent.com/trials/multimodal-imaging-study-on-physical-activity-in-patients-with-alzheimer-s-disease-64326https://curecurrent.com/trials/18f-florbetaben-pet-amyloid-imaging-in-case-of-intermediate-csf-biology-for-the-diagnosis-of-alzheimer-s-disease-a-pilot-64327https://curecurrent.com/trials/human-brain-antioxidants-during-oxidative-stress-64328https://curecurrent.com/trials/amyloid-and-tauopathy-pet-imaging-in-acute-and-chronic-traumatic-brain-injury-64329https://curecurrent.com/trials/measuring-cerebral-blood-flow-using-pseudo-continuous-arterial-spin-labeling-perfusion-magnetic-resonance-imaging-64330https://curecurrent.com/trials/effect-of-virtual-reality-on-balance-and-gait-speed-with-alzheimer-s-dementia-64331https://curecurrent.com/trials/safety-and-efficacy-of-tafamidis-in-patients-with-transthyretin-cardiomyopathy-64332https://curecurrent.com/trials/safety-and-efficacy-of-transcranial-electromagnetic-treatment-against-alzheimer-s-disease-64333https://curecurrent.com/trials/plasticity-based-adaptive-cognitive-remediation-for-alzheimer-disease-64334https://curecurrent.com/trials/early-diagnosis-and-early-treatment-of-alzheimer-s-disease-based-on-senile-plaque-imaging-64335https://curecurrent.com/trials/multi-center-imaging-genetics-studies-in-china-64336https://curecurrent.com/trials/the-pronto-study-a-global-phase-2b-study-of-neod001-in-previously-treated-subjects-with-light-chain-al-amyloidosis-64337https://curecurrent.com/trials/evaluation-of-123i-mni-340-and-spect-as-a-marker-of-beta-amyloid-protein-deposition-64338https://curecurrent.com/trials/evaluation-of-123i-mni-330-and-spect-as-a-marker-of-beta-amyloid-protein-deposition-64339https://curecurrent.com/trials/evaluation-of-18f-pbr06-and-pet-as-a-marker-of-inflammation-in-subjects-with-neurological-conditions-64340https://curecurrent.com/trials/single-photon-emission-computed-tomography-spect-imaging-study-to-develop-a-biomarker-for-alzheimer-s-disease-64341https://curecurrent.com/trials/detecting-dementia-earlier-64342https://curecurrent.com/trials/evaluation-of-123i-clinde-and-spect-as-a-marker-of-inflammation-in-subjects-with-pd-or-ad-and-in-healthy-subjects-64343https://curecurrent.com/trials/brain-imaging-study-in-subjects-with-alzheimer-disease-in-comparison-to-healthy-subjects-64344https://curecurrent.com/trials/a-pilot-study-to-reduce-inappropriate-anticholinergic-prescribing-in-the-elderly-64345https://curecurrent.com/trials/exercise-in-asymptomatic-pre-alzheimer-s-disease-pilot-study-64346https://curecurrent.com/trials/study-to-examine-the-safety-and-efficacy-of-pimavanserin-for-the-treatment-of-agitation-and-aggression-in-alzheimer-s-di-64347https://curecurrent.com/trials/multi-parameter-diagnostic-blood-test-for-the-diagnosis-of-alzheimer-s-disease-64348https://curecurrent.com/trials/phase-0-evaluation-of-18f-mni-958-as-a-potential-pet-radioligand-for-imaging-tau-protein-in-the-brain-64349https://curecurrent.com/trials/circle-dance-for-family-caregivers-of-the-elderly-with-alzheimer-64350https://curecurrent.com/trials/touchscreen-technology-and-art-for-people-with-dementia-in-care-homes-64351https://curecurrent.com/trials/the-brain-ketone-body-challenge-imaging-study-64352https://curecurrent.com/trials/evaluation-of-123i-av51-and-spect-as-a-marker-of-beta-amyloid-protein-deposition-in-subjects-with-alzheimer-disease-in-c-64353https://curecurrent.com/trials/comparison-of-once-daily-and-twice-daily-dosing-on-safety-and-tolerability-of-memantine-in-patients-with-alzheimer-64354https://curecurrent.com/trials/evaluation-of-123i-mni-187-and-spect-in-patients-with-alzheimers-disease-in-comparison-to-healthy-subjects-64355https://curecurrent.com/trials/effects-of-muscle-relaxation-on-cognitive-function-in-patients-with-mild-cognitive-impairment-and-early-stage-dementia-64356https://curecurrent.com/trials/korea-alzheimer-s-disease-neuroimaging-initiative-64357https://curecurrent.com/trials/mild-cognitive-impairment-and-obstructive-sleep-apnea-64358https://curecurrent.com/trials/evaluating-simvastatin-s-potential-role-in-therapy-64359https://curecurrent.com/trials/pet-imaging-study-using-11c-pib-in-subjects-with-ad-healthy-volunteers-64360https://curecurrent.com/trials/enhancing-working-memory-in-patients-with-early-alzheimer-s-disease-through-the-use-of-rtms-64361https://curecurrent.com/trials/neurofeedback-improves-cognitive-performance-and-eeg-activity-in-elderly-with-mild-cognitive-impairment-64362https://curecurrent.com/trials/a-decision-support-system-for-self-management-of-low-back-pain-pilotstudy-64363https://curecurrent.com/trials/efficacy-and-safety-of-t-817ma-in-patients-with-mild-to-moderate-alzheimer-s-disease-us202-64364https://curecurrent.com/trials/study-to-evaluate-safety-duration-in-stomach-of-extended-release-capsules-containing-memantine-hydrochloride-in-healthy-64365https://curecurrent.com/trials/short-term-effects-of-an-inpatient-geriatric-consultation-team-on-geriatric-syndrome-patients-64366https://curecurrent.com/trials/the-efficacy-of-traditional-chinese-herbal-medicine-for-dementia-64367https://curecurrent.com/trials/effect-of-egb761-on-brain-glucose-metabolism-in-three-groups-of-elderly-defined-by-cognitive-functions-64368https://curecurrent.com/trials/feasibility-trial-of-a-mediterranean-diet-pattern-to-prevent-cognitive-decline-64369https://curecurrent.com/trials/enhancing-care-coordination-hospital-to-home-for-cognitively-impaired-older-adults-and-their-caregivers-64370https://curecurrent.com/trials/study-investigating-the-effects-of-jnj-54861911-on-amyloid-beta-processing-in-cerebrospinal-fluid-csf-and-plasma-in-japa-64371https://curecurrent.com/trials/c-tracker-hepatitis-c-care-collaboration-patient-reported-outcomes-survey-study-64372https://curecurrent.com/trials/novel-retinal-imaging-biomarkers-in-early-alzheimer-s-disease-64373https://curecurrent.com/trials/indiana-university-dementia-screening-trial-64374https://curecurrent.com/trials/remindcare-app-for-patients-from-first-episode-of-psychosis-unit-64375https://curecurrent.com/trials/a-study-of-egb-761-tanakan-in-dementia-of-alzheimer-type-onset-in-patients-suffering-from-memory-complaints-64376https://curecurrent.com/trials/the-cognitive-and-cardiovascular-health-in-the-elderly-study-64377https://curecurrent.com/trials/pharmaceutical-collaborative-care-integrated-to-a-multidisciplinary-psychosocial-program-64378https://curecurrent.com/trials/natural-history-of-amyloid-deposition-in-adults-with-down-syndrome-64379https://curecurrent.com/trials/triggered-palliative-care-for-advanced-dementia-64380https://curecurrent.com/trials/study-of-degenerescence-csf-hallmarks-in-older-bipolar-patients-64381https://curecurrent.com/trials/evaluation-of-11c-ro6924963-11c-ro6931643-and-18f-ro6958948-as-tracers-for-positron-emission-tomography-pet-imaging-of-t-64382https://curecurrent.com/trials/evaluate-the-safety-and-efficacy-of-ad-35-tablet-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64383https://curecurrent.com/trials/a-study-on-the-effectiveness-of-multidomain-intervention-program-for-reducing-risks-of-dementia-64384https://curecurrent.com/trials/neuropsychological-and-neurophysiological-effects-of-cognitive-stimulation-in-patients-with-alzheimer-s-disease-and-mild-64385https://curecurrent.com/trials/paired-integrative-home-exercise-for-seniors-with-dementia-and-their-caregivers-pairedplie-64386https://curecurrent.com/trials/effects-of-dopaminergic-therapy-in-patients-with-alzheimer-s-disease-64387https://curecurrent.com/trials/reappraising-intergeneration-relationships-in-dementia-caregiving-64388https://curecurrent.com/trials/activity-of-masitinib-ab1010-in-mild-to-moderate-alzheimer-s-disease-64389https://curecurrent.com/trials/a-phase-3-study-to-evaluate-the-safety-and-tolerability-of-dimebon-patients-with-mild-to-moderate-alzheimer-s-disease-64390https://curecurrent.com/trials/study-evaluating-intepirdine-rvt-101-in-subjects-with-mild-to-moderate-alzheimer-s-disease-on-donepezil-mindset-study-64391https://curecurrent.com/trials/so-lo-mo-intervention-applied-to-the-smoking-cessation-process-64392https://curecurrent.com/trials/retinal-nerve-fiber-layer-thickness-and-cerebrospinal-fluid-a-tau-64393https://curecurrent.com/trials/a-phase-2-study-evaluating-the-efficacy-and-safety-of-pf-04494700-in-mild-to-moderate-alzheimer-s-disease-64394https://curecurrent.com/trials/alzheimer-disease-proof-of-concept-study-with-bi-409306-versus-placebo-64395https://curecurrent.com/trials/phase-2a-dose-finding-pk-pd-and-12-month-exploratory-efficacy-study-of-anavex2-73-in-patients-with-alzheimer-s-disease-64396https://curecurrent.com/trials/imaging-tau-in-alzheimer-s-disease-and-normal-aging-64397https://curecurrent.com/trials/bi-409306-in-patients-with-cognitive-impairment-due-to-alzheimer-s-disease-64398https://curecurrent.com/trials/18f-mk-3328-as-a-possible-novel-positron-emission-tomography-pet-tracer-for-the-detection-of-brain-amyloid-plaques-mk-33-64399https://curecurrent.com/trials/a-multiple-ascending-dose-study-of-cor388-64400https://curecurrent.com/trials/post-marketing-surveillance-of-long-term-administration-of-donepezil-hydrochloride-investigation-of-the-clinical-conditi-64401https://curecurrent.com/trials/a-fdg-pet-study-of-agn-242071-added-to-standard-of-care-donepezil-memantine-for-the-treatment-of-participants-with-mild-64402https://curecurrent.com/trials/impact-of-fbb-pet-amyloid-imaging-in-change-of-diagnosis-in-patients-with-ad-64403https://curecurrent.com/trials/first-in-human-study-of-single-and-multiple-ascending-doses-of-pf-06751979-64404https://curecurrent.com/trials/an-efficacy-and-safety-trial-of-verubecestat-mk-8931-in-mild-to-moderate-alzheimer-s-disease-p07738-64405https://curecurrent.com/trials/registry-of-amyloid-positive-patients-for-alzheimer-s-disease-drug-research-trials-64406https://curecurrent.com/trials/reveal-iii-risk-evaluation-and-education-for-alzheimer-s-disease-64407https://curecurrent.com/trials/risk-evaluation-and-education-for-alzheimer-s-disease-reveal-iv-64408https://curecurrent.com/trials/np001-alzheimer-s-disease-and-blood-markers-of-inflammation-64409https://curecurrent.com/trials/autologous-stem-stromal-cells-in-neurological-disorders-and-disease-64410https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-mk-0249-and-an-alzheimer-s-disease-medication-on-cognitive-function-in-adults-with-al-64411https://curecurrent.com/trials/study-to-evaluate-the-effects-of-bpn14770-on-scopolamine-induced-cognitive-impairment-in-healthy-volunteers-64412https://curecurrent.com/trials/risk-prediction-for-alzheimer-dementia-with-brain-imaging-and-genetics-64413https://curecurrent.com/trials/a-phase-1-randomized-open-label-two-way-crossover-study-to-evaluate-the-steady-state-effect-of-dimebon-pf-01913539-on-th-64414https://curecurrent.com/trials/effect-of-walking-on-brain-fuel-consumption-in-mild-alzheimer-s-disease-64415https://curecurrent.com/trials/molecular-cerebral-imaging-in-incipient-dementia-mci-id-ii-64416https://curecurrent.com/trials/new-approach-for-treatment-of-behavioral-disorders-in-alzheimer-s-disease-alzheimer-s-behavioral-and-cognitive-disorders-64417https://curecurrent.com/trials/computerized-cognition-testing-in-participants-with-mild-alzheimer-s-disease-ad-treated-with-donepezil-mk-0000-318-64418https://curecurrent.com/trials/fall-prevention-vestibular-rehabilitation-64419https://curecurrent.com/trials/an-efficacy-and-safety-study-of-sodium-oligo-mannurarate-gv-971-capsule-for-the-treatment-of-alzheimer-s-disease-64420https://curecurrent.com/trials/medium-chain-triglycerides-and-brain-metabolism-in-alzheimer-s-disease-64421https://curecurrent.com/trials/relationship-between-protein-biomarkers-in-cerebrospinal-fluid-and-alzheimer-apos-s-disease-in-patients-with-depression-64422https://curecurrent.com/trials/light-treatment-for-sleep-wake-disturbances-in-alzheimer-s-disease-64423https://curecurrent.com/trials/specialized-food-plan-based-on-individual-physiological-comprehensive-body-assessments-accompanied-with-cellular-repair-64424https://curecurrent.com/trials/an-open-label-study-investigating-mk-8931-in-participants-with-mild-and-moderate-hepatic-insufficiency-mk-8931-016-64425https://curecurrent.com/trials/feasibility-and-efficacy-of-the-ketogenic-diet-in-alzheimer-s-disease-64426https://curecurrent.com/trials/medical-food-formulation-pharmacokinetic-pk-study-in-medium-chain-triglycerides-64427https://curecurrent.com/trials/efficacy-of-1072nm-infrared-stimulation-on-executive-functioning-in-dementia-64428https://curecurrent.com/trials/study-of-retinal-findings-in-people-with-signs-and-symptoms-of-alzheimer-s-disease-enrolled-in-09-m-0198-64429https://curecurrent.com/trials/the-effectiveness-and-safety-of-donepezil-hydrochloride-e2020-in-subjects-with-mild-to-severe-alzheimer-s-disease-residi-64430https://curecurrent.com/trials/laughter-therapy-effects-on-mood-stress-and-self-efficacy-in-people-with-neurological-diseases-64431https://curecurrent.com/trials/a-phase-2a-study-to-evaluate-the-effect-of-rilapladib-sb-659032-in-alzheimer-s-disease-64432https://curecurrent.com/trials/18f-mk-6240-positron-emission-tomography-pet-tracer-first-in-human-validation-study-mk-6240-001-64433https://curecurrent.com/trials/efficacy-and-safety-of-mk-7622-as-adjunct-therapy-in-participants-with-alzheimer-s-disease-mk-7622-012-64434https://curecurrent.com/trials/clinical-trial-in-healthy-volunteers-and-health-elderly-volunteers-to-evaluate-the-safety-tolerability-and-blood-concent-64435https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-heat-application-on-the-delivery-profile-of-corplex-donepezil-transdermal-delivery-sys-64436https://curecurrent.com/trials/webnovela-for-hispanic-dementia-family-caregivers-64437https://curecurrent.com/trials/corticolimbic-degeneration-and-treatment-of-dementia-64438https://curecurrent.com/trials/post-marketing-surveillance-of-donepezil-hydrochloride-investigation-of-the-safety-and-effectiveness-of-combination-ther-64439https://curecurrent.com/trials/post-marketing-surveillance-of-donepezil-hydrochloride-investigation-of-the-factors-that-affect-aricept-medication-persi-64440https://curecurrent.com/trials/mild-cognitive-impairment-use-of-qeeg-as-a-prognostic-marker-64441https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-tolerability-profiles-of-g-csf-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64442https://curecurrent.com/trials/enhancing-spatial-navigation-using-non-invasive-brain-stimulation-64443https://curecurrent.com/trials/m-learning-to-improve-professional-competencies-in-health-sciences-64444https://curecurrent.com/trials/evidence-amyloid-scan-eeg-study-64445https://curecurrent.com/trials/alzheimer-s-disease-therapeutic-potential-of-estrogen-64446https://curecurrent.com/trials/aftobetin-hcl-and-fluorescence-detection-measured-by-sapphire-ii-to-determine-the-number-and-timing-of-administrations-64447https://curecurrent.com/trials/the-depression-in-alzheimer-s-disease-study-diads-64448https://curecurrent.com/trials/eeg-cholinergic-index-and-clinical-response-to-treatment-with-cholinesterase-inhibitors-64449https://curecurrent.com/trials/differential-effects-of-various-anesthetic-agents-on-cognitive-function-in-patients-with-alzheimer-s-disease-64450https://curecurrent.com/trials/long-term-safety-and-tolerability-of-idalopirdine-lu-ae58054-as-adjunctive-treatment-to-donepezil-in-patients-with-mild-64451https://curecurrent.com/trials/expanded-access-with-trappsol-r-cyclo-tm-for-an-individual-patient-with-late-onset-alzheimer-s-disease-64452https://curecurrent.com/trials/adverse-drug-reactions-in-older-subjects-64453https://curecurrent.com/trials/optimal-dose-escalation-strategy-to-successful-achievement-of-high-dose-donepezil-23mg-64454https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-pharmacokinetics-pk-of-corplex-donepezil-transdermal-delivery-system-tds-applied-to-dif-64455https://curecurrent.com/trials/dementia-specific-intervention-of-advance-care-planning-64456https://curecurrent.com/trials/individualized-prediction-of-migraine-attacks-using-a-mobile-phone-app-and-fitbit-64457https://curecurrent.com/trials/prospective-evaluation-of-a-smartphone-application-gocheckkids-to-detect-amblyopia-risk-factors-in-young-children-64458https://curecurrent.com/trials/effects-of-an-8-component-botanical-supplement-on-mild-and-moderate-alzheimer-s-patients-64459https://curecurrent.com/trials/a-phase-1-corplex-donepezil-transdermal-system-compared-to-oral-aricept-64460https://curecurrent.com/trials/a-bioequivalence-study-of-corplex-donepezil-transdermal-delivery-system-compared-to-aricept-64461https://curecurrent.com/trials/feasibility-study-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64462https://curecurrent.com/trials/study-of-sb-742457-or-donepezil-versus-placebo-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64463https://curecurrent.com/trials/clinical-trial-of-ct1812-in-mild-to-moderate-alzheimer-s-disease-64464https://curecurrent.com/trials/aging-stereotypes-and-prodromal-alzheimer-s-disease-64465https://curecurrent.com/trials/living-with-frontotemporal-dementia-64466https://curecurrent.com/trials/exploring-the-use-of-transdermal-methylphenidate-to-reduce-fall-risk-in-patients-with-dementia-64467https://curecurrent.com/trials/efficacy-and-safety-of-cx516-in-elderly-participants-with-mild-cognitive-impairment-64468https://curecurrent.com/trials/multi-centre-study-of-htl0018318-in-patients-as-an-add-on-to-standard-of-care-64469https://curecurrent.com/trials/endeavour-phase-3-multicenter-study-of-revusiran-aln-ttrsc-in-patients-with-transthyretin-ttr-mediated-familial-amyloido-64470https://curecurrent.com/trials/clinical-evaluation-of-florbetapir-f-18-18f-av-45-64471https://curecurrent.com/trials/allyquest-engaging-hiv-ymsm-in-care-through-social-networking-and-gamification-64472https://curecurrent.com/trials/validation-of-the-montreal-cognitive-assessment-in-patients-with-mild-and-major-neurocognitive-disorder-64473https://curecurrent.com/trials/olfactory-deficits-in-mci-as-predictor-of-improved-cognition-on-donepezil-64474https://curecurrent.com/trials/gait-disorders-in-patients-with-cognitive-decline-64475https://curecurrent.com/trials/a-study-assessing-bryostatin-in-the-treatment-of-moderately-severe-to-severe-alzheimer-s-disease-64476https://curecurrent.com/trials/screening-and-evaluation-of-patients-with-signs-and-symptoms-of-alzheimer-s-disease-64477https://curecurrent.com/trials/health-ebrain-study-64478https://curecurrent.com/trials/a-non-drug-methods-study-in-participants-with-alzheimer-s-disease-64479https://curecurrent.com/trials/blood-brain-barrier-opening-using-focused-ultrasound-with-iv-contrast-agents-in-patients-with-early-alzheimer-s-disease-64480https://curecurrent.com/trials/apathy-in-dementia-methylphenidate-trial-admet-64481https://curecurrent.com/trials/good-rate-of-clinical-response-to-cholinesterase-inhibitors-in-alzheimer-s-disease-after-three-months-of-treatment-64482https://curecurrent.com/trials/efficacy-and-safety-study-of-abt-288-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64483https://curecurrent.com/trials/efficacy-of-circadin-2-mg-in-patients-with-mild-to-moderate-alzheimer-disease-treated-with-ache-inhibitor-64484https://curecurrent.com/trials/normative-values-for-the-german-version-of-the-montreal-cognitive-assessment-moca-64485https://curecurrent.com/trials/alzheimer-s-disease-and-physiological-cognitive-function-and-bdnf-levels-of-plasma-adaptation-after-exercise-training-64486https://curecurrent.com/trials/validation-of-the-sleep-assessment-algorithm-in-the-medical-application-nightly-64487https://curecurrent.com/trials/study-of-ly2886721-in-mild-cognitive-impairment-due-to-alzheimer-s-disease-or-mild-alzheimer-s-disease-64488https://curecurrent.com/trials/nrc-improving-healthcare-for-cognitively-impaired-elders-and-their-caregivers-64489https://curecurrent.com/trials/safety-follow-up-study-for-subjects-with-agitation-associated-with-dementia-of-the-alzheimer-s-type-who-previously-parti-64490https://curecurrent.com/trials/open-label-study-of-trx0014-in-alzheimer-s-disease-64491https://curecurrent.com/trials/safety-and-exploratory-efficacy-study-of-ucmscs-in-patients-with-alzheimer-s-disease-64492https://curecurrent.com/trials/shanghai-mild-cognitive-impairment-cohort-study-64493https://curecurrent.com/trials/tolerability-of-rivastigmine-before-and-after-switching-from-oral-formulation-to-transdermal-patch-in-alzheimer-s-dement-64494https://curecurrent.com/trials/skeletal-muscle-as-a-mediator-of-exercise-induced-effects-on-metabolism-cognitive-function-role-for-myokines-mirnas-64495https://curecurrent.com/trials/the-genetic-characterization-of-dementia-64496https://curecurrent.com/trials/early-markers-of-cognitive-change-and-alzheimer-s-disease-64497https://curecurrent.com/trials/in-vivo-imaging-of-therapeutic-electric-current-flow-64498https://curecurrent.com/trials/positron-emission-tomography-pet-study-in-patients-with-alzheimer-s-disease-64499https://curecurrent.com/trials/clinical-pharmacology-of-p38-map-kinase-inhibitor-vx-745-in-mild-cognitive-impairment-due-to-alzheimer-s-disease-ad-or-m-64500https://curecurrent.com/trials/prevention-of-depression-in-spouses-of-people-with-cognitive-impairment-64501https://curecurrent.com/trials/p75ntr-diagnostic-biomarker-for-alzheimer-s-disease-quantification-study-in-cerebrospinal-fluid-64502https://curecurrent.com/trials/optical-coherence-tomography-in-cerebral-amyloidosis-64503https://curecurrent.com/trials/a-repeated-dose-study-of-khk6640-in-japanese-patients-with-alzheimer-s-disease-64504https://curecurrent.com/trials/effects-of-doxycycline-and-rifampicin-on-biomarkers-of-alzheimer-s-disease-in-the-cerebrospinal-fluid-64505https://curecurrent.com/trials/safety-and-efficacy-study-evaluating-trx0237-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64506https://curecurrent.com/trials/prevention-of-alzheimer-s-disease-by-vitamin-e-and-selenium-preadvise-64507https://curecurrent.com/trials/safety-and-efficacy-study-evaluating-trx0237-in-subjects-with-mild-alzheimer-s-disease-64508https://curecurrent.com/trials/evaluation-of-a-smartphone-application-gocheckkids-as-a-photo-screening-tool-in-a-pediatric-population-64509https://curecurrent.com/trials/connected-solution-of-assistance-dedicated-to-caregivers-and-people-with-alzheimer-s-disease-or-related-diseases-64510https://curecurrent.com/trials/the-effects-of-acupuncture-on-the-risk-of-ad-after-tbi-64511https://curecurrent.com/trials/behavioral-expressions-in-alzheimer-s-disease-64512https://curecurrent.com/trials/idalopirdine-in-patients-with-mild-moderate-alzheimer-s-disease-treated-with-donepezil-64513https://curecurrent.com/trials/assessing-neurovisual-function-in-patients-with-cognitive-impairment-64514https://curecurrent.com/trials/statins-in-cerebral-blood-flow-and-neuronal-activity-a-pilot-study-64515https://curecurrent.com/trials/efficacy-of-orm-12741-on-agitation-aggression-symptoms-in-alzheimer-s-disease-64516https://curecurrent.com/trials/study-of-idalopirdine-in-patients-with-mild-moderate-alzheimer-s-disease-treated-with-an-acetylcholinesterase-inhibitor-64517https://curecurrent.com/trials/music-therapy-in-alzheimer-s-disease-64518https://curecurrent.com/trials/trial-of-carvedilol-in-alzheimer-s-disease-64519https://curecurrent.com/trials/alzheimer-s-disease-acitretin-medication-64520https://curecurrent.com/trials/donepezil-and-brain-activity-patterns-in-those-at-risk-for-alzheimer-s-disease-64521https://curecurrent.com/trials/cognitive-changes-in-alzheimer-s-disease-patients-associated-with-or-without-white-matter-changes-after-rivastigmine-64522https://curecurrent.com/trials/venlafaxine-for-depression-in-alzheimer-s-disease-diads-3-64523https://curecurrent.com/trials/dosage-and-efficacy-of-probucol-induced-apoe-to-negate-cognitive-deterioration-64524https://curecurrent.com/trials/evaluating-and-implementing-a-smartphone-application-treatment-program-for-bulimia-nervosa-and-binge-eating-disorder-64525https://curecurrent.com/trials/cognitive-motor-intervention-using-virtual-reality-for-middle-aged-individuals-at-high-dementia-risk-64526https://curecurrent.com/trials/memantine-and-comprehensive-individualized-patient-centered-management-of-alzheimer-s-disease-health-outcome-64527https://curecurrent.com/trials/deep-transcranial-magnetic-stimulation-for-treatment-of-alzheimer-s-disease-64528https://curecurrent.com/trials/enhancing-neuroplasticity-and-frontal-lobe-function-in-patients-with-mild-alzheimer-s-disease-64529https://curecurrent.com/trials/daoib-for-the-treatment-of-cognitive-function-and-behavioral-and-psychological-symptoms-of-dementia-64530https://curecurrent.com/trials/reported-time-between-onset-and-diagnosis-of-alzheimer-s-disease-correlation-with-objective-parameters-64531https://curecurrent.com/trials/efficacy-and-safety-of-prj212-to-improve-the-memory-of-patients-with-mild-severity-alzheimer-s-disease-64532https://curecurrent.com/trials/the-coach-project-combined-online-assistance-for-caregiver-health-64533https://curecurrent.com/trials/fornix-and-nbm-as-targets-of-stimulation-in-alzheimer-s-disease-64534https://curecurrent.com/trials/narcolepsy-protect-against-alzheimer-s-disease-64535https://curecurrent.com/trials/response-to-donepezil-drug-plasma-concentration-and-the-cyp2d6-and-apoe-genetic-polymorphisms-64536https://curecurrent.com/trials/disrupted-sleep-neuroendocrine-status-and-the-behavioral-symptoms-of-ad-64537https://curecurrent.com/trials/lescod-lewy-body-screening-in-cognitive-disorders-64538https://curecurrent.com/trials/a-study-of-sb-742457-added-to-donepezil-for-the-treatment-of-mild-to-moderate-alzheimer-s-disease-64539https://curecurrent.com/trials/cns-and-plasma-amyloid-beta-kinetics-in-alzheimer-s-disease-64540https://curecurrent.com/trials/effectiveness-of-flash-mediation-therapy-64541https://curecurrent.com/trials/treatment-for-aggression-and-agitation-in-patients-with-alzheimer-s-disease-64542https://curecurrent.com/trials/rosiglitazone-extended-release-tablets-as-adjunctive-therapy-for-subjects-with-mild-to-moderate-alzheimer-s-disease-64543https://curecurrent.com/trials/study-to-assess-the-safety-and-effects-of-autologous-adipose-derived-stromal-cells-in-patients-with-alzheimer-s-disease-64544https://curecurrent.com/trials/study-of-iti-007-in-healthy-geriatric-volunteers-and-in-geriatric-patients-with-dementia-64545https://curecurrent.com/trials/open-label-extension-study-of-rosiglitazone-xr-as-adjunctive-therapy-in-subjects-with-mild-to-moderate-alzheimers-64546https://curecurrent.com/trials/cataract-removal-and-alzheimer-s-disease-64547https://curecurrent.com/trials/study-of-rosiglitazone-xr-in-subjects-with-mild-to-moderate-alzheimers-64548https://curecurrent.com/trials/chromatic-pupillometry-to-assess-the-melanopsin-light-pathway-in-progressive-supranuclear-palsy-64549https://curecurrent.com/trials/study-to-evaluate-the-preliminary-safety-efficacy-pk-and-pd-of-bryostatin-1-in-patients-with-alzheimer-s-disease-64550https://curecurrent.com/trials/central-and-systemic-inflammation-in-alzheimer-s-disease-64551https://curecurrent.com/trials/cognitive-behavioral-treatment-for-mild-alzheimer-s-patients-and-their-caregivers-64552https://curecurrent.com/trials/evaluation-of-18f-ro6958948-as-tracer-for-positron-emission-tomography-pet-imaging-of-tau-burden-in-alzheimer-s-disease-64553https://curecurrent.com/trials/imaging-of-cognition-learning-and-memory-in-aging-64554https://curecurrent.com/trials/a-study-of-the-safety-and-efficacy-of-pimavanserin-in-patients-with-alzheimer-s-disease-psychosis-64555https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-single-oral-escalating-doses-of-gsk2647544-in-healthy-volun-64556https://curecurrent.com/trials/therapeutic-role-of-transcranial-dcs-in-alzheimer-64557https://curecurrent.com/trials/aripiprazole-for-the-treatment-of-patients-with-agitation-associated-with-dementia-of-the-alzheimer-s-type-64558https://curecurrent.com/trials/efficacy-and-safety-of-the-rivastigmine-transdermal-patch-in-patients-with-probable-alzheimer-s-disease-64559https://curecurrent.com/trials/tdcs-effect-on-cognitive-functions-from-patients-with-alzheimer-s-disease-or-progressive-primary-aphasia-64560https://curecurrent.com/trials/self-directed-online-training-for-chinese-caregivers-64561https://curecurrent.com/trials/the-plasma-for-alzheimer-symptom-amelioration-plasma-study-64562https://curecurrent.com/trials/evaluation-of-18f-mni-952-as-a-potential-pet-radioligand-for-imaging-tau-protein-in-the-brain-64563https://curecurrent.com/trials/application-of-diffusion-tensor-imaging-in-alzheimer-s-disease-quantification-of-white-matter-micro-structural-changes-64564https://curecurrent.com/trials/clinical-trial-to-evaluate-the-efficacy-and-security-of-deep-brain-stimulation-in-alzheimer-s-disease-64565https://curecurrent.com/trials/effect-of-insulin-sensitizer-metformin-on-ad-biomarkers-64566https://curecurrent.com/trials/long-term-extension-safety-study-in-patients-with-dementia-of-the-alzheimer-s-type-who-completed-study-cpc-001-07-64567https://curecurrent.com/trials/study-of-idalopirdine-in-patients-with-mild-moderate-alzheimer-s-disease-treated-with-donepezil-64568https://curecurrent.com/trials/polyphenols-and-risk-of-dementia-64569https://curecurrent.com/trials/reducing-disabilities-in-alzheimer-s-disease-rdad-translation-in-area-agencies-on-aging-aaas-64570https://curecurrent.com/trials/the-university-of-hong-kong-neurocognitive-disorder-cohort-64571https://curecurrent.com/trials/rosiglitazone-extended-release-tablets-as-adjunctive-therapy-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64572https://curecurrent.com/trials/repetitive-transcranial-magnetic-stimulation-in-patients-with-alzheimer-disease-64573https://curecurrent.com/trials/effectiveness-of-care-management-in-alzheimer-patients-64574https://curecurrent.com/trials/co-lesions-in-alzheimer-disease-and-related-disorders-64575https://curecurrent.com/trials/levetiracetam-and-memory-function-in-amnestic-mild-cognitive-impairment-mci-64576https://curecurrent.com/trials/mobile-phone-app-for-depression-and-anxiety-in-young-men-who-are-attracted-to-men-64577https://curecurrent.com/trials/the-cognitive-resilience-study-64578https://curecurrent.com/trials/efficacy-and-safety-of-ramelteon-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64579https://curecurrent.com/trials/dose-ranging-safety-and-tolerability-study-in-subjects-60-years-of-age-64580https://curecurrent.com/trials/development-of-a-new-neuroimaging-method-aimed-to-differentiate-mnesic-abilities-of-alzheimer-and-depressed-patients-64581https://curecurrent.com/trials/cpc-201-alzheimer-s-disease-type-dementia-pet-study-64582https://curecurrent.com/trials/evaluation-of-the-animal-intervention-used-as-therapy-64583https://curecurrent.com/trials/a-study-to-demonstrate-the-bioequivalence-of-rosiglitazone-xr-brl-049653-8mgs-xr-manufactured-at-two-different-sites-64584https://curecurrent.com/trials/brain-computer-interface-system-for-training-memory-and-attention-in-elderly-64585https://curecurrent.com/trials/randomized-trial-of-low-dose-naproxen-in-cognitively-intact-persons-at-risk-of-alzheimer-s-dementia-64586https://curecurrent.com/trials/eye-movement-recording-as-an-early-differential-diagnostic-tool-for-alzheimer-depression-64587https://curecurrent.com/trials/omegad-omega-3-and-alzheimer-s-disease-64588https://curecurrent.com/trials/effects-of-simvastatin-on-biomarkers-64589https://curecurrent.com/trials/a-phase-3-clinical-trial-to-evaluate-the-efficacy-and-safety-of-18f-nav4694-pet-for-detection-of-cerebral-beta-amyloid-w-64590https://curecurrent.com/trials/clinical-pathway-for-alzheimer-s-disease-in-china-cpad-64591https://curecurrent.com/trials/disulfiram-as-a-modulator-of-amyloid-precursor-protein-processing-64592https://curecurrent.com/trials/a-study-of-ro7105705-in-healthy-participants-and-participants-with-mild-to-moderate-alzheimer-s-disease-64593https://curecurrent.com/trials/fish-oil-and-alpha-lipoic-acid-in-treating-alzheimer-s-disease-64594https://curecurrent.com/trials/pk-dose-proportionality-food-effect-and-repeat-dose-study-of-rosiglitazone-xr-in-healthy-volunteers-64595https://curecurrent.com/trials/a-clinical-study-to-assess-single-and-repeat-doses-of-a-new-medication-gsk933776-in-patients-with-alzheimer-s-disease-64596https://curecurrent.com/trials/validation-of-a-scale-of-well-being-assessment-siwa-in-patients-with-alzheimer-s-disease-or-a-related-disease-64597https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-mabt5102a-in-patients-with-mild-to-moderate-alzheimer-s-disease-abby-64598https://curecurrent.com/trials/a-study-to-evaluate-the-impact-of-mabt5102a-on-brain-amyloid-load-and-related-biomarkers-in-patients-with-mild-to-modera-64599https://curecurrent.com/trials/bridging-study-with-gsk239512-in-patients-with-mild-to-moderate-alzheimer-s-disease-64600https://curecurrent.com/trials/the-evaluation-and-follow-up-of-individuals-with-memory-disorder-64601https://curecurrent.com/trials/clinical-and-genetic-studies-of-familial-presenile-dementia-with-neuronal-inclusion-bodies-64602https://curecurrent.com/trials/mri-of-alzheimer-s-disease-imaging-amyloid-plaques-in-persons-with-and-without-memory-problems-64603https://curecurrent.com/trials/treatment-study-of-frontotemporal-dementia-64604https://curecurrent.com/trials/effects-of-a-combined-transcranial-magnetic-stimulation-tms-and-cognitive-training-in-alzheimer-patients-64605https://curecurrent.com/trials/pet-imaging-of-brain-amyloid-using-11c-mes-impy-64606https://curecurrent.com/trials/deep-brain-stimulation-for-treatment-of-severe-alzheimer-s-disease-64607https://curecurrent.com/trials/evaluation-of-age-and-alzheimer-s-disease-related-memory-disorder-64608https://curecurrent.com/trials/effects-of-an-anti-inflammatory-drug-in-alzheimer-s-disease-64609https://curecurrent.com/trials/brain-uptake-of-gsk1034702-a-positron-emission-tomography-pet-scan-study-64610https://curecurrent.com/trials/phase-i-healthy-subject-safety-tolerability-and-pharmacokinetic-study-of-an-m1-agonist-to-treat-cognitive-impairment-64611https://curecurrent.com/trials/serotonergic-pharmacotherapy-for-agitation-of-dementia-64612https://curecurrent.com/trials/a-3-year-study-to-evaluate-the-safety-and-efficacy-of-low-dose-ladostigil-in-patients-with-mild-cognitive-impairment-64613https://curecurrent.com/trials/modulation-of-abeta-levels-by-gsk933776-in-alzheimer-s-disease-patient-64614https://curecurrent.com/trials/gsk2647544-rd-ddi-in-healthy-young-and-elderly-volunteers-64615https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-of-e2609-and-its-metabolites-in-subjects-with-mild-and-moderate-hepatic-impairm-64616https://curecurrent.com/trials/comparison-of-pet-amyloid-imaging-in-japanese-and-western-subjects-64617https://curecurrent.com/trials/verification-study-and-reactivity-study-for-the-validity-of-ququ-scale-64618https://curecurrent.com/trials/safety-and-tolerability-of-pq912-in-subjects-with-early-alzheimer-s-disease-64619https://curecurrent.com/trials/study-evaluating-the-long-term-safety-and-efficacy-of-subcutaneous-bapineuzumab-64620https://curecurrent.com/trials/detecting-early-myocardial-infiltration-w-amyloid-light-chain-deposition-disease-in-multiple-myeloma-subjects-64621https://curecurrent.com/trials/evaluation-of-my-tools-4-care-for-family-caregivers-of-persons-with-dementia-64622https://curecurrent.com/trials/memantine-treatment-in-alzheimer-s-disease-patients-64623https://curecurrent.com/trials/a-study-of-ro4602522-in-participants-with-moderate-severity-alzheimer-disease-on-background-alzheimer-disease-therapy-64624https://curecurrent.com/trials/open-label-extension-assessing-long-term-safety-of-rosiglitazone-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64625https://curecurrent.com/trials/zolpidem-cr-and-hospitalized-patients-with-dementia-64626https://curecurrent.com/trials/rosiglitazone-extended-release-tablets-as-monotherapy-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64627https://curecurrent.com/trials/effect-of-electroacupuncture-combined-with-donepezil-for-treating-alzheimer-s-disease-64628https://curecurrent.com/trials/research-on-the-early-and-prognosis-diagnosis-of-vascular-dementia-64629https://curecurrent.com/trials/a-based-on-peeg-and-pet-study-of-anxiolytic-treatment-to-improve-cognitive-function-in-patients-with-alzheimer-disease-64630https://curecurrent.com/trials/neuro-imaging-and-multimodal-alzheimer-s-disease-64631https://curecurrent.com/trials/bupropion-for-the-treatment-of-apathy-in-alzheimer-s-dementia-64632https://curecurrent.com/trials/effects-of-triglycerides-on-age-related-cognitive-function-decline-in-older-subjects-64633https://curecurrent.com/trials/computational-tools-for-early-diagnosis-of-memory-disorders-64634https://curecurrent.com/trials/down-syndrome-biomarker-initiative-dsbi-64635https://curecurrent.com/trials/metabolic-cerebral-imaging-in-incipient-dementia-mci-id-64636https://curecurrent.com/trials/apathy-associated-with-alzheimer-s-disease-64637https://curecurrent.com/trials/study-to-evaluate-coconut-oil-for-alzheimer-s-disease-64638https://curecurrent.com/trials/discontinuation-of-cholinesterase-inhibitors-for-the-treatment-of-severe-alzheimer-s-disease-64639https://curecurrent.com/trials/alzheimers-disease-and-neuromarkers-in-patients-with-acute-hip-fractures-64640https://curecurrent.com/trials/optimisation-of-antipsychotic-drug-use-in-older-people-64641https://curecurrent.com/trials/bridging-study-of-c11-pittsburgh-compound-b-pib-and-f18-flutemetamol-brain-positron-emission-tomography-pet-64642https://curecurrent.com/trials/volunteers-adding-life-in-dementia-64643https://curecurrent.com/trials/the-primary-care-dementia-assessment-and-treatment-algorithm-64644https://curecurrent.com/trials/can-the-assessment-of-the-subhippocampal-region-contribute-to-the-detection-of-early-diagnosis-of-alzheimer-s-disease-a-64645https://curecurrent.com/trials/repeated-subcutaneous-administration-of-abvac40-in-mild-to-moderate-alzheimer-s-disease-patients-64646https://curecurrent.com/trials/volunteers-adding-life-in-dementia-valid-64647https://curecurrent.com/trials/lipoic-acid-and-omega-3-fatty-acids-for-alzheimer-s-disease-64648https://curecurrent.com/trials/study-to-evaluate-the-efficacy-and-safety-of-gsk239512-in-alzheimer-s-disease-64649https://curecurrent.com/trials/hearing-instruments-in-alzheimer-s-disease-64650https://curecurrent.com/trials/depression-in-alzheimer-s-disease-2-64651https://curecurrent.com/trials/influence-of-beta-amyloid-imaging-on-care-of-patients-cognitive-complaints-64652https://curecurrent.com/trials/safety-study-of-sargramostim-in-treating-patients-with-mild-cognitive-impairment-due-to-alzheimer-s-disease-64653https://curecurrent.com/trials/pilot-study-lipoic-acid-and-omega-3-fatty-acids-for-alzheimer-s-prevention-64654https://curecurrent.com/trials/the-effect-of-memantine-on-brain-structure-and-chemistry-in-alzheimer-s-disease-patients-64655https://curecurrent.com/trials/brain-aging-project-kansas-university-64656https://curecurrent.com/trials/efficacy-of-pain-treatment-on-depression-in-patients-with-dementia-64657https://curecurrent.com/trials/the-effects-of-anesthesia-on-patients-undergoing-surgery-for-repair-of-a-thoracoabdominal-aneurysm-64658https://curecurrent.com/trials/effects-of-a-neuroad-system-for-the-treatment-of-alzheimer-disease-64659https://curecurrent.com/trials/deep-brain-stimulation-for-the-treatment-of-alzheimer-s-disease-64660https://curecurrent.com/trials/neurogenetic-pharmaceuticals-ngp-555-in-healthy-volunteers-14-day-multiple-ascending-dose-64661https://curecurrent.com/trials/atp-in-alzheimer-disease-64662https://curecurrent.com/trials/compliance-and-tolerability-of-rivastigmine-transdermal-patch-10-cm-in-patients-with-probable-alzheimer-s-disease-64663https://curecurrent.com/trials/study-evaluating-thesafety-and-efficacy-of-pf-05212377-or-placebo-in-subjects-with-alzheimer-s-disease-with-existing-neu-64664https://curecurrent.com/trials/18-months-safety-follow-up-study-of-aadvac1-an-active-tau-vaccine-for-alzheimer-s-disease-64665https://curecurrent.com/trials/pilot-study-of-aerobic-exercise-in-early-alzheimer-s-disease-ad-64666https://curecurrent.com/trials/open-label-extension-study-evaluating-safety-and-tolerability-of-aab-003-pf-05236812-in-subject-with-mild-to-moderate-al-64667https://curecurrent.com/trials/florbetapir-calibration-to-the-centiloid-scale-64668https://curecurrent.com/trials/quantitative-evaluation-of-18f-t807-as-a-potential-pet-radioligand-for-imaging-tau-in-patients-with-alzheimer-s-disease-64669https://curecurrent.com/trials/a-24-weeks-multi-center-randomized-double-blind-placebo-controlled-study-to-evaluate-the-efficacy-and-safety-of-donepezi-64670https://curecurrent.com/trials/a-plan-on-investigation-and-collection-of-aricept-safety-information-with-a-dose-increase-on-alzheimer-s-disease-patient-64671https://curecurrent.com/trials/a-phase-iii-trial-of-nilvadipine-to-treat-alzheimer-s-disease-64672https://curecurrent.com/trials/therapy-of-alzheimer-s-disease-with-neurofeedback-64673https://curecurrent.com/trials/an-exploratory-study-to-compare-the-differences-in-nutritional-status-between-patients-with-mild-and-moderate-alzheimer-64674https://curecurrent.com/trials/apoe-impact-study-on-brain-structure-and-function-in-a-population-45-to-75-years-old-64675https://curecurrent.com/trials/comparative-research-of-alzheimer-s-disease-drugs-64676https://curecurrent.com/trials/a-12-week-multicenter-open-label-evaluation-of-caregiver-preference-safety-and-tolerability-of-exelon-patch-rivastigmine-64677https://curecurrent.com/trials/caregiver-stress-interventions-to-promote-health-and-wellbeing-64678https://curecurrent.com/trials/an-open-label-extension-to-evaluate-the-efficacy-and-safety-of-the-rivastigmine-transdermal-patch-in-patients-with-proba-64679https://curecurrent.com/trials/study-evaluating-the-safety-of-aab-003-pf-05236812-in-subjects-with-alzheimer-s-disease-64680https://curecurrent.com/trials/effect-of-therapeutic-light-on-sleep-circadian-rhythm-and-global-function-in-women-with-alzheimer-s-64681https://curecurrent.com/trials/16w-interventional-study-on-titration-and-dose-efficacy-assessment-of-exelon-in-chinese-alzheimer-s-disease-patients-64682https://curecurrent.com/trials/a-study-of-the-safety-and-tolerability-of-azd5213-effect-on-sleep-for-patients-with-alzheimer-s-cognitive-impairment-64683https://curecurrent.com/trials/phase-1-study-investigating-effects-of-htl0009936-on-cognition-and-bold-fmri-signals-in-healthy-elderly-subjects-64684https://curecurrent.com/trials/roflumilast-and-donepezil-to-reverse-scopolamine-induced-cognitive-deficits-in-healthy-adults-64685https://curecurrent.com/trials/isotopic-imaging-for-prodromal-alzheimer-s-disease-64686https://curecurrent.com/trials/the-alzheimer-s-disease-therapy-with-neuroaid-athene-study-64687https://curecurrent.com/trials/effects-of-chromium-on-insulin-resistance-in-alzheimer-disease-patients-64688https://curecurrent.com/trials/magnesium-sulfate-for-the-improvement-of-cognition-in-patients-with-alzheimer-disease-64689https://curecurrent.com/trials/impact-of-physical-activity-on-successful-aging-64690https://curecurrent.com/trials/safety-study-of-nicotinamide-to-treat-alzheimer-s-disease-64691https://curecurrent.com/trials/orientation-in-ad-patients-pet-mr-study-64692https://curecurrent.com/trials/bpn14770-single-ascending-dose-study-in-healthy-male-and-female-subjects-64693https://curecurrent.com/trials/a-multiple-ascending-dose-study-of-bpn14770-in-healthy-young-and-elderly-male-or-female-subjects-64694https://curecurrent.com/trials/triglyceride-rich-lipoprotein-and-development-of-dementia-64695https://curecurrent.com/trials/ability-telerehabilitation-technology-enhanced-multi-domain-at-home-continuum-of-care-program-64696https://curecurrent.com/trials/absolute-bioavailability-of-a-single-fixed-subcutaneous-dose-of-aducanumab-in-healthy-participants-64697https://curecurrent.com/trials/treatment-of-language-and-memory-in-patients-with-alzheimer-s-disease-64698https://curecurrent.com/trials/a-pet-brain-imaging-study-of-mglur5-in-subjects-with-neuropsychiatric-conditions-64699https://curecurrent.com/trials/behavioral-and-neuroimaging-changes-after-cognitive-rehab-in-traumatic-brain-injuries-tbi-and-mild-cognitive-impairment-64700https://curecurrent.com/trials/non-pharmacological-care-of-alzheimer-s-disease-benefice-of-musical-interventions-64701https://curecurrent.com/trials/evaluation-of-e2609-in-subjects-with-mild-cognitive-impairment-or-mild-dementia-due-to-alzheimer-s-disease-study-e2609-a-64702https://curecurrent.com/trials/a-multi-national-study-to-identify-treatment-discontinuation-rate-in-de-novo-alzheimer-s-disease-patients-who-have-been-64703https://curecurrent.com/trials/an-innovative-caregiver-tool-to-assess-and-manage-behavioral-symptoms-of-dementia-64704https://curecurrent.com/trials/evaluation-of-18f-mni-777-pet-as-a-marker-of-tau-pathology-in-subjects-with-tauopathies-compared-to-healthy-subjects-64705https://curecurrent.com/trials/evaluation-of-18f-mni-815-as-a-potential-pet-radioligand-for-imaging-tau-protein-in-the-brain-of-patients-with-tauopathi-64706https://curecurrent.com/trials/efficacy-and-safety-of-mni-672-spect-for-detection-exclusion-of-cerebral-b-amyloid-in-ad-subjects-compared-to-hvs-64707https://curecurrent.com/trials/neurofeedback-as-a-novel-treatment-for-mild-cognitive-impairment-early-alzheimer-s-disease-64708https://curecurrent.com/trials/study-to-determine-the-effect-of-itraconazole-on-the-pharmacokinetics-of-rilapladib-sb659032-in-healthy-volunteers-64709https://curecurrent.com/trials/tai-chi-6-form-sports-apparatus-with-alzheimer-s-disease-64710https://curecurrent.com/trials/a-single-dose-study-of-khk6640-in-japanese-patients-with-alzheimer-s-disease-64711https://curecurrent.com/trials/research-on-pathophysiology-and-treatment-in-depression-using-brain-derived-neurotrophic-factor-and-amyloid-neuroimaging-64712https://curecurrent.com/trials/mass-practice-of-activities-of-daily-living-in-dementia-stomp-64713https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-rivastigmine-patch-in-patients-with-mild-to-moderate-alzheimer-s-disease-switched-fr-64714https://curecurrent.com/trials/the-cognitive-effects-of-lorazepam-in-healthy-older-individuals-with-tomm40-variable-length-polymorphisms-64715https://curecurrent.com/trials/mild-alzheimer-s-disease-to-assess-the-of-extended-release-formulation-of-rosiglitazone-rsg-xr-64716https://curecurrent.com/trials/establishment-of-a-bank-of-biospecimens-for-future-research-on-age-related-cognitive-disorders-64717https://curecurrent.com/trials/a-multiple-ascending-dose-study-of-r1450-in-patients-with-alzheimer-disease-64718https://curecurrent.com/trials/a-study-of-ro4602522-in-patients-with-alzheimer-disease-and-in-healthy-volunteers-64719https://curecurrent.com/trials/a-study-of-ro5313534-as-add-on-to-donepezil-treatment-in-patients-with-mild-to-moderate-alzheimer-s-disease-64720https://curecurrent.com/trials/a-clinical-trial-for-an-evaluation-of-choline-alfoscerate-and-donepezil-for-cognitive-improvements-of-patients-with-cere-64721https://curecurrent.com/trials/fmri-of-vulnerable-brain-regions-in-persons-at-risk-for-alzheimer-s-disease-64722https://curecurrent.com/trials/improving-dementia-caregiver-sleep-the-effect-on-heart-disease-biomarkers-64723https://curecurrent.com/trials/memantine-and-comprehensive-individualized-management-of-alzheimer-s-disease-and-caregiver-training-64724https://curecurrent.com/trials/alzheimer-s-disease-anti-inflammatory-prevention-trial-adapt-64725https://curecurrent.com/trials/relative-bioavailability-study-in-healthy-subjects-to-evaluate-the-pharmacokinetics-of-htl0009936-after-one-dose-of-prot-64726https://curecurrent.com/trials/the-safety-and-efficacy-of-long-term-treatment-of-pins-stimulator-system-for-patients-with-alzheimer-s-disease-64727https://curecurrent.com/trials/cytokines-and-cognitive-decline-in-alzheimer-s-disease-64728https://curecurrent.com/trials/the-study-of-mechanism-of-alzheimer-s-disease-using-acupuncture-based-on-fmri-64729https://curecurrent.com/trials/a-safety-and-efficacy-study-evaluating-dimebon-latrepirdine-in-patients-with-moderate-to-severe-alzheimer-s-disease-64730https://curecurrent.com/trials/an-extension-of-the-concert-protocol-dim18-64731https://curecurrent.com/trials/a-validation-study-of-the-novel-application-of-telehealth-in-clinical-drug-development-in-subjects-with-mild-cognitive-d-64732https://curecurrent.com/trials/a-safety-and-efficacy-study-of-oral-dimebon-in-patients-with-mild-to-moderate-alzheimer-s-disease-64733https://curecurrent.com/trials/safety-and-efficacy-study-evaluating-dimebon-in-patients-with-mild-to-moderate-alzheimer-s-disease-on-donepezil-64734https://curecurrent.com/trials/gait-and-alzheimer-interaction-tracking-gait-study-64735https://curecurrent.com/trials/alzheimer-s-disease-input-of-vitamin-d-with-memantine-assay-64736https://curecurrent.com/trials/support-by-singing-sessions-on-physical-and-moral-pain-assessment-of-its-effectiveness-in-alzheimer-s-disease-64737https://curecurrent.com/trials/pre-clinical-alzheimers-diagnosis-pcd-optimum-outcomes-oo-64738https://curecurrent.com/trials/overuse-of-antidepressant-in-patients-with-alzheimer-disease-64739https://curecurrent.com/trials/distance-savvy-testing-tele-savvy-a-distance-dementia-family-caregiver-education-program-64740https://curecurrent.com/trials/the-effect-of-repeated-transcranial-magnetic-stimulation-on-off-line-resting-electroencephalographic-signal-in-alzheimer-64741https://curecurrent.com/trials/ascending-dose-study-of-ct1812-in-healthy-volunteers-64742https://curecurrent.com/trials/construction-of-diagnosis-system-for-early-ad-based-on-multi-modality-mri-technology-64743https://curecurrent.com/trials/conservation-of-praxis-in-the-food-and-alzheimer-disease-64744https://curecurrent.com/trials/effectiveness-of-florbetapir-18f-pet-imaging-in-changing-patient-management-and-the-relationship-between-scan-status-and-64745https://curecurrent.com/trials/s-equol-in-alzheimer-s-disease-sead-trial-64746https://curecurrent.com/trials/identification-of-epigenetic-markers-common-to-obesity-and-alzheimer-s-disease-in-women-64747https://curecurrent.com/trials/sleep-apnea-in-early-to-mid-stage-alzheimer-s-disease-64748https://curecurrent.com/trials/comparative-effectiveness-of-mci-and-dementia-treatments-in-a-community-based-dementia-practice-64749https://curecurrent.com/trials/randomized-double-blind-study-to-evaluate-the-tolerability-of-2-different-titration-methods-of-rivastigmine-patch-in-ad-64750https://curecurrent.com/trials/cognitive-morphological-and-neurobiological-progressive-aspects-in-bipolar-disorders-in-the-elderly-toward-to-a-neurodeg-64751https://curecurrent.com/trials/enteric-nervous-system-in-alzheimer-disease-64752https://curecurrent.com/trials/discovery-a-study-examining-the-prevalence-of-ttr-mutations-in-subjects-suspected-of-having-cardiac-amyloidosis-64753https://curecurrent.com/trials/exploratory-study-for-the-validity-of-ququ-scale-64754https://curecurrent.com/trials/safety-study-of-avp-923-in-the-treatment-of-ieed-involuntary-emotional-expression-disorder-also-known-as-pseudobulbar-af-64755https://curecurrent.com/trials/sensory-cognitive-and-physical-fitness-training-in-mild-cognitive-impairment-64756https://curecurrent.com/trials/effects-of-visual-arts-training-on-dementia-64757https://curecurrent.com/trials/memora-caregiver-risk-factors-of-caregiver-burden-among-patients-with-neurocognitive-disorders-or-subjective-cognitive-c-64758https://curecurrent.com/trials/phase-i-single-and-multiple-escalating-dose-study-of-rgn1016-in-healthy-male-subjects-64759https://curecurrent.com/trials/safety-and-efficacy-of-donepezil-hcl-23-mg-in-patients-with-moderate-to-severe-alzheimer-s-disease-64760https://curecurrent.com/trials/african-american-alzheimer-s-progression-markers-csf-and-neuro-imaging-64761https://curecurrent.com/trials/efficacy-and-safety-of-plasma-exchange-with-5-albumin-in-beta-amyloid-peptide-clearance-in-cerebral-spinal-fluid-64762https://curecurrent.com/trials/resveratrol-for-alzheimer-s-disease-64763https://curecurrent.com/trials/reducing-cvd-risk-in-caregivers-a-brief-behavioral-activation-intervention-64764https://curecurrent.com/trials/study-evaluating-the-safety-and-efficacy-of-bapineuzumab-in-alzheimer-disease-patients-64765https://curecurrent.com/trials/determinants-of-quality-of-life-related-to-health-in-alzheimer-disease-64766https://curecurrent.com/trials/study-to-evaluate-the-effect-of-a-vegetal-oil-on-cognitive-impairment-64767https://curecurrent.com/trials/a-study-of-acupuncture-for-patients-with-behavioural-and-psychological-symptoms-of-dementia-64768https://curecurrent.com/trials/phase-iii-study-of-florbetaben-bay94-9172-pet-imaging-for-detection-exclusion-of-cerebral-amyloid-compared-to-histopatho-64769https://curecurrent.com/trials/treatment-of-behavioral-symptoms-in-alzheimer-s-disease-64770https://curecurrent.com/trials/oculomotor-testing-in-the-differential-diagnosis-of-dementia-64771https://curecurrent.com/trials/partners-in-dementia-care-a-telephone-care-consultation-intervention-provided-to-veterans-in-partnership-with-local-alzh-64772https://curecurrent.com/trials/mk0952-in-patients-with-mild-to-moderate-alzheimer-s-disease-0952-004-completed-64773https://curecurrent.com/trials/neurostimulation-and-cognitive-intervention-in-alzheimer-s-disease-64774https://curecurrent.com/trials/alzheimer-s-disease-biomarkers-in-cerebrospinal-fluid-in-insulin-resistant-men-64775https://curecurrent.com/trials/short-term-efficacy-and-safety-of-perispinal-administration-of-etanercept-in-mild-to-moderate-alzheimer-s-disease-64776https://curecurrent.com/trials/impact-of-pharmacotherapy-management-in-patients-with-alzheimer-s-disease-64777https://curecurrent.com/trials/study-for-the-tolerability-of-exelon-patch-rivastigmine-for-alzheimer-s-disease-ad-patients-64778https://curecurrent.com/trials/study-of-the-safety-and-effectiveness-of-two-doses-of-investigational-study-drug-evp-6124-in-subjects-with-alzheimer-s-d-64779https://curecurrent.com/trials/study-of-the-safety-and-effectiveness-of-two-doses-of-investigational-study-drug-evp-6124-in-subjects-with-alzheimer-s-d-64780https://curecurrent.com/trials/study-of-the-safety-and-clinical-effects-of-2-doses-of-evp-6124-in-subjects-with-alzheimer-s-disease-who-complete-study-64781https://curecurrent.com/trials/efficacy-of-ubiquitous-sr-based-memory-advancement-and-rehabilitation-training-u-smart-64782https://curecurrent.com/trials/effect-of-aqw051-in-patients-with-memory-impairment-64783https://curecurrent.com/trials/study-to-explore-the-optimal-dosage-administration-in-alzheimer-s-disease-64784https://curecurrent.com/trials/retrospective-cohort-study-of-the-efficacy-of-axona-medium-chain-triglycerides-in-patients-with-alzheimer-s-disease-64785https://curecurrent.com/trials/a-long-term-extension-study-evaluating-acc-001-with-qs-21-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64786https://curecurrent.com/trials/effect-of-neuroad-on-the-cognitive-function-of-alzheimer-patients-64787https://curecurrent.com/trials/efficacy-and-safety-of-the-pet-imaging-agent-18f-nav4694-in-subjects-with-probable-alzheimer-s-disease-64788https://curecurrent.com/trials/is-there-a-relationship-between-previous-exposure-to-general-anesthesia-and-the-development-of-alzheimer-s-disease-64789https://curecurrent.com/trials/semantic-memory-financial-capacity-and-brain-perfusion-in-mild-cognitive-impairment-mci-casl-64790https://curecurrent.com/trials/omental-transposition-surgery-for-mild-alzheimer-s-disease-64791https://curecurrent.com/trials/effects-of-light-therapy-in-alzheimer-s-disease-64792https://curecurrent.com/trials/effect-of-different-doses-of-sar110894-on-cognition-in-patients-with-mild-to-moderate-alzheimer-s-disease-on-donepezil-64793https://curecurrent.com/trials/memory-problems-perceptions-among-patients-and-accompaniers-during-diagnosis-process-64794https://curecurrent.com/trials/alzheimer-s-disease-multiple-intervention-trial-64795https://curecurrent.com/trials/a-clinical-trial-of-a-vitamin-nutriceutical-formulation-for-alzheimer-s-disease-64796https://curecurrent.com/trials/amyloid-imaging-and-safety-study-of-acc-001-in-subjects-with-early-alzheimer-s-disease-64797https://curecurrent.com/trials/safety-and-efficiency-of-umbilical-cord-derived-mesenchymal-stem-cells-uc-msc-in-patients-with-alzheimer-s-disease-64798https://curecurrent.com/trials/early-counseling-and-support-for-alzheimer-s-disease-caregivers-64799https://curecurrent.com/trials/24-week-open-label-extension-study-evaluating-pxt00864-effect-in-mild-ad-patients-further-to-pleodial-i-completion-64800https://curecurrent.com/trials/dose-response-study-of-aerobic-exercise-in-older-adults-64801https://curecurrent.com/trials/pilot-study-assessing-the-effects-of-pxt00864-in-patients-with-mild-alzheimer-disease-ad-64802https://curecurrent.com/trials/bexarotene-amyloid-treatment-for-alzheimer-s-disease-64803https://curecurrent.com/trials/normalization-of-dyrk1a-and-app-function-as-an-approach-to-improve-cognitive-performance-and-decelerate-ad-progression-i-64804https://curecurrent.com/trials/the-role-of-mid-life-adiposity-in-functional-brain-connectivity-64805https://curecurrent.com/trials/fluoroav45-imaging-research-in-alzheimer-s-disease-64806https://curecurrent.com/trials/using-hypnotherapy-for-dementia-alzheimer-s-64807https://curecurrent.com/trials/study-evaluating-safety-tolerability-and-pk-of-multiple-ascending-doses-of-gc021109-in-subjects-with-mild-to-moderate-al-64808https://curecurrent.com/trials/the-trinity-ulster-and-department-of-agriculture-cohort-study-64809https://curecurrent.com/trials/the-eyes-have-it-ocular-saccade-abnormalities-in-prodromal-alzheimer-s-disease-64810https://curecurrent.com/trials/group-therapy-for-caregivers-of-alzheimer-s-disease-patients-in-spanish-elderly-persons-centres-64811https://curecurrent.com/trials/detection-of-disease-related-changes-in-pre-symptomatic-alzheimer-s-disease-64812https://curecurrent.com/trials/a-composite-mr-neuroimaging-marker-for-alzheimer-s-disease-64813https://curecurrent.com/trials/enhanced-external-counterpulsation-and-its-effects-on-vascular-hemodynamics-in-cognitively-impaired-patients-64814https://curecurrent.com/trials/neurogenetic-pharmaceuticals-ngp-555-in-healthy-young-volunteers-single-ascending-dose-64815https://curecurrent.com/trials/development-of-therapeutic-intervention-for-sleep-in-alzheimer-caregiver-dyads-64816https://curecurrent.com/trials/evaluation-of-safety-tolerability-of-multiple-dose-regimens-of-chf-5074-64817https://curecurrent.com/trials/study-evaluating-the-efficacy-and-safety-of-bapineuzumab-in-alzheimer-disease-patients-64818https://curecurrent.com/trials/clinical-trial-of-donepezil-between-the-patients-with-alzheimer-s-disease-and-mixed-dementia-64819https://curecurrent.com/trials/characteristics-of-treatment-responders-to-galantamine-64820https://curecurrent.com/trials/clinical-trial-of-donepezil-between-the-naive-group-and-the-switching-group-64821https://curecurrent.com/trials/coordinating-center-for-caregiver-intervention-trial-64822https://curecurrent.com/trials/apps-to-reduce-the-impact-that-adverse-events-among-health-professionals-64823https://curecurrent.com/trials/study-evaluating-acc-001-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64824https://curecurrent.com/trials/study-evaluating-acc-001-in-japanese-patients-with-mild-to-moderate-alzheimer-s-disease-64825https://curecurrent.com/trials/a-long-term-safety-and-tolerability-extension-study-of-bapineuzumab-in-alzheimer-disease-patients-64826https://curecurrent.com/trials/study-evaluating-safety-tolerability-and-immunogenicity-of-acc-001-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64827https://curecurrent.com/trials/safety-tolerability-and-immunogenicity-study-of-acc-001-in-japanese-subjects-with-mild-to-moderate-alzheimer-s-disease-64828https://curecurrent.com/trials/amyloid-related-imaging-abnormalities-microbleeds-in-atypical-ad-64829https://curecurrent.com/trials/alzheimer-patients-and-the-snoezelen-program-64830https://curecurrent.com/trials/a-longitudinal-multidimensional-population-study-on-brain-aging-64831https://curecurrent.com/trials/study-of-combination-therapy-with-dimebon-and-donepezil-aricept-in-patients-with-alzheimer-s-disease-64832https://curecurrent.com/trials/gray-matters-alzheimer-s-disease-prevention-intervention-64833https://curecurrent.com/trials/patients-with-behavioural-symptoms-and-hospitalized-in-cognitive-and-behavioural-units-64834https://curecurrent.com/trials/improving-mood-and-behavior-in-assisted-living-residents-through-skills-training-for-their-caregivers-64835https://curecurrent.com/trials/a-study-to-assess-effect-of-jnj-54861911-on-pharmacokinetics-of-cocktail-representatives-for-cytochrome-p450-cyp-3a4-cyp-64836https://curecurrent.com/trials/methylphenidate-for-apathy-in-alzheimer-s-dementia-a-controlled-study-64837https://curecurrent.com/trials/low-dose-opiate-therapy-for-discomfort-in-dementia-l-dot-64838https://curecurrent.com/trials/safety-study-of-mt-4666-in-subjects-with-alzheimer-s-disease-64839https://curecurrent.com/trials/double-blind-placebo-controlled-study-of-oral-dimebon-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64840https://curecurrent.com/trials/safety-and-tolerability-of-dimebon-in-patients-on-memantine-and-memantine-plus-donepezil-64841https://curecurrent.com/trials/pharmacokinetic-properties-of-idalopirdine-lu-ae58054-in-subjects-with-and-without-impaired-kidney-function-64842https://curecurrent.com/trials/safety-radiation-dosimetry-biokinetics-and-effectiveness-of-18f-mk3328-mk-3328-001-64843https://curecurrent.com/trials/identification-of-biomarkers-sensitive-to-disease-progression-in-patients-with-mild-cognitive-impairment-64844https://curecurrent.com/trials/memory-training-in-patients-with-amnestic-mild-cognitive-impairment-64845https://curecurrent.com/trials/cerebrolysin-compared-to-donepezil-in-patients-with-mild-to-moderate-dementia-of-alzheimer-s-type-dat-64846https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-pharmacodynamics-of-mk-8931-in-participants-with-alzheimer-s-disease-mk-8931-010-64847https://curecurrent.com/trials/early-onset-and-late-onset-sporadic-alzheimer-s-disease-ad-64848https://curecurrent.com/trials/safety-and-effectiveness-study-of-intranasal-insulin-glulisine-on-cognitive-and-memory-in-mild-mod-ad-patients-64849https://curecurrent.com/trials/study-of-the-safety-of-two-doses-of-investigational-study-drug-evp-6124-in-subjects-with-alzheimer-s-disease-currently-r-64850https://curecurrent.com/trials/safety-study-of-aadvac1-a-tau-peptide-klh-conjugate-active-vaccine-to-treat-alzheimer-s-disease-64851https://curecurrent.com/trials/a-multicenter-double-blind-placebo-controlled-safety-and-tolerability-study-of-bms-708163-in-patients-with-prodromal-alz-64852https://curecurrent.com/trials/a-phase-ii-multicenter-double-blind-placebo-controlled-safety-tolerability-study-of-bms-708163-in-patients-with-mild-to-64853https://curecurrent.com/trials/posterior-cingulate-function-in-persons-with-risk-factors-for-alzheimer-s-disease-64854https://curecurrent.com/trials/cognitive-and-neurophysiological-effects-of-raloxifene-in-alzheimer-s-disease-64855https://curecurrent.com/trials/contribution-of-actigraphy-and-recognition-video-in-apathy-assessment-of-alzheimer-s-disease-experimental-research-64856https://curecurrent.com/trials/yoga-for-family-caregivers-of-alzheimers-disease-patient-64857https://curecurrent.com/trials/safety-and-efficacy-of-mt-4666-64858https://curecurrent.com/trials/evaluation-of-reader-training-processes-64859https://curecurrent.com/trials/a-study-of-v950-in-people-with-alzheimer-disease-v950-001-am7-64860https://curecurrent.com/trials/assessment-of-social-emotional-functioning-in-neurological-diseases-64861https://curecurrent.com/trials/retrieval-of-patient-information-after-discontinuation-64862https://curecurrent.com/trials/vanquishing-apathy-through-e-inclusion-using-realistic-virtual-environment-project-64863https://curecurrent.com/trials/usability-of-virtual-reality-in-subjects-with-mild-cognitive-impairment-or-alzheimer-s-disease-64864https://curecurrent.com/trials/a-study-to-test-the-performance-of-the-cogstate-computerized-neuropsychological-battery-in-patients-with-alzheimer-s-dis-64865https://curecurrent.com/trials/pilot-study-of-the-effects-of-resveratrol-supplement-in-mild-to-moderate-alzheimer-s-disease-64866https://curecurrent.com/trials/specific-care-and-assistance-plan-for-alzheimer-s-disease-64867https://curecurrent.com/trials/physical-training-and-cognitive-activity-on-the-mild-cognitive-impairment-mci-patient-64868https://curecurrent.com/trials/cerebral-substrates-of-prospective-memory-in-young-and-its-disruption-in-normal-aging-and-in-alzheimer-s-disease-a-study-64869https://curecurrent.com/trials/a-study-to-evaluate-the-effect-of-bexarotene-on-beta-amyloid-and-apolipoprotein-e-metabolism-in-healthy-subjects-64870https://curecurrent.com/trials/cognitive-behavior-therapy-for-treating-anxiety-in-people-with-dementia-64871https://curecurrent.com/trials/transcranial-direct-current-stimulation-tdcs-as-a-cognitive-enhancer-for-patients-with-alzheimers-disease-64872https://curecurrent.com/trials/a-study-to-assess-regional-cerebral-blood-flow-as-an-alzheimer-s-disease-biomarker-compared-to-positron-emission-tomogra-64873https://curecurrent.com/trials/markers-of-alzheimers-disease-after-propofol-or-isoflurane-anesthesia-64874https://curecurrent.com/trials/alzheimer-s-disease-art-and-garden-64875https://curecurrent.com/trials/what-elements-of-the-design-of-a-healing-garden-are-used-as-landmarks-by-patients-with-alzheimer-s-disease-to-locate-64876https://curecurrent.com/trials/study-of-mk0677-for-the-treatment-of-alzheimer-s-disease-0677-030-completed-64877https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-an-indwelling-catheter-to-obtain-cerebrospinal-fluid-csf-by-low-rate-continuous-sampling-64878https://curecurrent.com/trials/memory-and-insulin-in-early-alzheimer-s-disease-64879https://curecurrent.com/trials/the-feasibility-of-florbetapir-quantitation-in-europe-64880https://curecurrent.com/trials/telesupport-evaluation-of-professionally-led-support-groups-for-caregivers-64881https://curecurrent.com/trials/the-feasibility-of-florbetapir-quantitation-64882https://curecurrent.com/trials/reminiscence-anxiety-and-early-alzheimer-s-disease-64883https://curecurrent.com/trials/a-study-to-evaluate-the-effects-of-jnj-54861911-on-amyloid-beta-processing-in-cerebrospinal-fluid-and-plasma-in-patients-64884https://curecurrent.com/trials/follow-up-study-to-assess-safety-and-clinical-activity-of-continued-affitope-ad02-vaccinations-of-patients-who-participa-64885https://curecurrent.com/trials/escitalopram-treatment-for-bpsd-in-alzheimer-s-disease-in-comparison-to-risperidone-64886https://curecurrent.com/trials/catie-alzheimer-s-disease-trial-64887https://curecurrent.com/trials/alzheimer-s-disease-core-center-64888https://curecurrent.com/trials/two-interventions-for-early-stage-dementia-a-comparative-efficacy-trial-64889https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-study-to-assess-safety-tolerability-pharmacokinetics-immunogenicity-and-pha-64890https://curecurrent.com/trials/efficacy-safety-tolerability-of-azd3480-patients-with-mild-to-moderate-dementia-of-the-alzheimer-s-type-ad-64891https://curecurrent.com/trials/preventing-loss-of-independence-through-exercise-pli-pilot-64892https://curecurrent.com/trials/health-technology-assessment-of-diagnostic-approaches-in-alzheimer-s-disease-64893https://curecurrent.com/trials/reducing-caregiver-stress-and-sleep-disturbances-in-patients-with-progressive-dementia-64894https://curecurrent.com/trials/olfactory-neuroepithelial-tissue-of-alzheimer-disease-64895https://curecurrent.com/trials/safety-and-efficacy-of-divalproex-and-quetiapine-in-elderly-alzheimer-s-dementia-patients-64896https://curecurrent.com/trials/sound-estimation-and-accuracy-task-64897https://curecurrent.com/trials/prazosin-treatment-for-disruptive-agitation-in-alzheimer-s-disease-64898https://curecurrent.com/trials/brain-changes-by-rivastigmine-according-to-butyrylcholinesterase-alleles-64899https://curecurrent.com/trials/project-act-advancing-caregiving-techniques-64900https://curecurrent.com/trials/telephone-support-for-dementia-caregivers-64901https://curecurrent.com/trials/study-to-evaluate-dietary-supplementation-with-a-version-of-anatabloc-r-in-subjects-with-alzheimer-s-disease-64902https://curecurrent.com/trials/online-caregiver-psychoeducation-and-support-for-alzheimer-s-64903https://curecurrent.com/trials/sensory-support-care-for-elderly-patients-suffering-from-alzheimer-s-type-neurodegenerative-disease-64904https://curecurrent.com/trials/home-safety-clinical-trial-for-alzheimer-s-disease-64905https://curecurrent.com/trials/effect-of-cerefolin-cerefolinnac-on-biomarker-measurements-64906https://curecurrent.com/trials/study-of-the-pharmacokinetics-and-pharmacodynamics-of-posiphen-in-subjects-with-amnestic-mild-cognitive-impairment-64907https://curecurrent.com/trials/qtc-study-of-rosi-xr-in-healthy-volunteers-64908https://curecurrent.com/trials/prediction-of-cognitive-properties-of-new-drug-candidates-for-neurodegenerative-diseases-in-early-clinical-development-64909https://curecurrent.com/trials/effect-of-activity-on-sleep-of-cognitively-impaired-veterans-64910https://curecurrent.com/trials/telehealth-education-program-for-caregivers-of-veterans-with-dementia-64911https://curecurrent.com/trials/testing-the-effectiveness-of-telephone-support-for-dementia-caregivers-64912https://curecurrent.com/trials/nurse-managed-clinic-for-dementia-patients-and-family-caregivers-64913https://curecurrent.com/trials/supporting-caregivers-of-persons-with-dementia-a-pilot-study-64914https://curecurrent.com/trials/pain-management-and-behavioral-outcomes-in-patients-with-dementia-64915https://curecurrent.com/trials/raloxifene-for-women-with-alzheimer-s-disease-64916https://curecurrent.com/trials/intervention-programs-for-decreasing-caregiver-burden-in-caregivers-of-patients-with-dementia-64917https://curecurrent.com/trials/single-and-repeated-dosing-study-to-assess-the-safety-and-the-concentration-time-profile-of-sar228810-in-alzheimer-s-pat-64918https://curecurrent.com/trials/a-phase-i-clinical-study-randomized-single-blind-placebo-controlled-multiple-doses-dose-escalation-study-of-the-safety-t-64919https://curecurrent.com/trials/a-positron-emission-tomography-pet-study-evaluating-brain-metabolism-of-a-medical-food-in-alzheimer-s-disease-64920https://curecurrent.com/trials/single-ascending-dose-study-of-biib037-in-participants-with-alzheimer-s-disease-64921https://curecurrent.com/trials/effect-of-ly450139-on-the-long-term-progression-of-alzheimer-s-disease-64922https://curecurrent.com/trials/effects-of-strengthening-exercise-on-the-brain-for-early-dementia-and-normative-older-adults-64923https://curecurrent.com/trials/cellular-proteome-from-leukocytes-of-glaucoma-patients-in-comparison-with-patients-with-alzheimer-s-disease-64924https://curecurrent.com/trials/early-diagnosis-of-alzheimer-like-dementia-benefit-of-mri-and-pet-imaging-64925https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-aricept-in-patients-with-severe-alzheimer-s-disease-who-are-living-in-skilled-nurs-64926https://curecurrent.com/trials/study-of-repetitive-transcranial-magnetic-stimulation-rtms-as-add-on-treatment-for-early-alzheimer-s-disease-64927https://curecurrent.com/trials/effects-of-ly450139-on-the-progression-of-alzheimer-s-disease-as-compared-with-placebo-64928https://curecurrent.com/trials/mk0249-for-the-symptomatic-treatment-of-alzheimer-s-disease-mk0249-011-64929https://curecurrent.com/trials/amylo-d-load-in-elderly-population-effect-of-cognitive-reserve-64930https://curecurrent.com/trials/a-safety-study-of-ttp4000-in-subjects-with-alzheimer-s-disease-64931https://curecurrent.com/trials/study-to-evaluate-the-effects-of-food-ingestion-on-the-pharmacokinetics-of-chf-5074-in-healthy-young-male-subjects-64932https://curecurrent.com/trials/safety-pharmacokinetics-and-pharmacodynamics-study-of-treatment-with-chf-5074-in-healthy-young-male-subjects-64933https://curecurrent.com/trials/study-to-evaluate-safety-pharmacokinetics-and-pharmacodynamics-of-chf5074-in-healthy-young-male-subjects-64934https://curecurrent.com/trials/evaluation-of-effects-of-multiple-dose-regimens-of-chf-5074-on-potential-biomarkers-of-neurodegeneration-in-subjects-wit-64935https://curecurrent.com/trials/treatment-of-elderly-subjects-with-psychosis-and-behavioral-disturbances-associated-with-dementia-of-the-alzheimer-s-typ-64936https://curecurrent.com/trials/multi-modality-mri-study-on-prediction-for-mild-cognitive-impairment-conversion-64937https://curecurrent.com/trials/patients-with-alzheimer-disease-spouse-carers-and-risk-of-institutionalization-a-prospective-observational-cohort-study-64938https://curecurrent.com/trials/safety-efficacy-and-dose-titration-of-sodium-oligo-mannurarate-capsule-on-mild-to-moderate-alzheimer-s-disease-64939https://curecurrent.com/trials/a-two-part-single-dose-study-of-the-pharmacokinetics-of-mk-8931-in-subjects-with-renal-insufficiency-mk-8931-009-p08535-64940https://curecurrent.com/trials/efficacy-study-of-a-zt-1-implant-in-patients-suffering-from-alzheimer-s-disease-64941https://curecurrent.com/trials/evaluation-of-zk-6032924-in-probable-alzheimer-s-disease-patients-versus-healthy-volunteers-and-the-radiation-dosimetry-64942https://curecurrent.com/trials/liwa-for-treatment-of-alzheimer-patients-64943https://curecurrent.com/trials/amyloid-imaging-and-safety-study-of-acc-001-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64944https://curecurrent.com/trials/telephone-resources-and-assistance-for-caregivers-trac-64945https://curecurrent.com/trials/long-term-extension-study-evaluating-safety-tolerability-and-immunogenicity-of-acc-001-in-japanese-subjects-with-mild-to-64946https://curecurrent.com/trials/collaboration-between-department-of-old-age-psychiatry-and-nursing-homes-64947https://curecurrent.com/trials/physical-exercise-as-an-additional-treatment-for-alzheimer-disease-64948https://curecurrent.com/trials/effect-of-physical-exercise-in-alzheimer-patients-64949https://curecurrent.com/trials/home-evaluation-of-exit-barriers-in-wandering-64950https://curecurrent.com/trials/f-18-av-45-uptake-spot-sign-presence-and-cerebral-amyloid-angiopathy-caa-in-primary-intracranial-hemorrhage-ich-64951https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-abt-126-in-subjects-with-mild-to-moderate-alzheimer-s-disease-64952https://curecurrent.com/trials/3-month-study-of-msdc-0160-effects-on-brain-glucose-utilization-cognition-safety-in-subjects-with-alzheimer-s-disease-64953https://curecurrent.com/trials/outcome-predictors-of-a-cognitive-intervention-in-amci-64954https://curecurrent.com/trials/a-study-to-investigate-the-safety-tolerability-and-pharmacokinetics-of-jnj-54861911-in-healthy-volunteers-compared-with-64955https://curecurrent.com/trials/mechanisms-of-insulin-facilitation-of-memory-64956https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-abt-126-in-subjects-with-mild-to-moderate-alzheimer-s-disease-on-stable-doses-of-ace-64957https://curecurrent.com/trials/meditation-or-education-for-alzheimer-caregivers-64958https://curecurrent.com/trials/effects-of-sage-on-memory-and-mental-performance-in-alzheimer-s-disease-patients-64959https://curecurrent.com/trials/evaluating-cerebrospinal-fluid-biomarkers-in-alzheimer-s-progressive-supranuclear-palsy-subjects-and-controls-64960https://curecurrent.com/trials/memantine-plus-es-citalopram-in-elderly-depressed-patients-with-cognitive-impairment-64961https://curecurrent.com/trials/the-use-of-eeg-in-alzheimer-s-disease-with-and-without-scopolamine-a-pilot-study-64962https://curecurrent.com/trials/evaluation-of-electronic-florbetapir-18f-interpretation-training-in-japanese-physicians-64963https://curecurrent.com/trials/effects-of-memantine-on-magnetic-resonance-mr-spectroscopy-in-subjects-at-risk-for-alzheimer-s-disease-64964https://curecurrent.com/trials/capacity-assessment-in-persons-with-alzheimer-s-disease-64965https://curecurrent.com/trials/a-study-to-assess-effects-of-clarithromycin-on-pharmacokinetics-of-jnj-54861911-in-healthy-male-participants-64966https://curecurrent.com/trials/alzheimer-disease-rehabilitation-s-intervention-at-home-64967https://curecurrent.com/trials/a-study-to-evaluate-bioavailability-food-effect-safety-and-tolerability-of-a-solid-dosage-formulation-of-jnj-54861911-in-64968https://curecurrent.com/trials/the-paco-study-personnalit-alzheimer-comportement-64969https://curecurrent.com/trials/imaging-characteristics-of-florbetapir-18f-in-patients-with-frontotemporal-dementia-alzheimer-s-disease-and-normal-contr-64970https://curecurrent.com/trials/efficacy-and-safety-of-talsaclidine-in-patients-with-mild-to-moderate-dementia-of-alzheimer-type-64971https://curecurrent.com/trials/efficacy-and-safety-of-talsaclidine-free-base-in-patients-with-mild-to-moderate-dementia-of-alzheimer-type-64972https://curecurrent.com/trials/valproate-in-dementia-valid-64973https://curecurrent.com/trials/follow-up-trial-to-assess-the-long-term-safety-and-tolerability-of-talsaclidine-in-patients-with-mild-to-moderate-dement-64974https://curecurrent.com/trials/minocycline-in-patients-with-alzheimer-s-disease-64975https://curecurrent.com/trials/a-study-of-semagacestat-for-alzheimer-s-patients-64976https://curecurrent.com/trials/dha-docosahexaenoic-acid-an-omega-3-fatty-acid-in-slowing-the-progression-of-alzheimer-s-disease-64977https://curecurrent.com/trials/cognitive-rehabilitation-in-alzheimer-s-disease-64978https://curecurrent.com/trials/a-multiple-dose-study-of-gantenerumab-in-japanese-alzheimer-apos-s-disease-patients-64979https://curecurrent.com/trials/home-based-assessment-for-alzheimer-disease-prevention-64980https://curecurrent.com/trials/alzheimer-s-disease-neuroimaging-initiative-grand-opportunity-64981https://curecurrent.com/trials/adni-alzheimer-s-disease-neuroimaging-initiative-64982https://curecurrent.com/trials/a-safety-tolerability-and-pharmacokinetics-study-of-jnj-54861911-in-healthy-japanese-male-participants-64983https://curecurrent.com/trials/the-predictive-factors-of-good-clinical-response-to-cholinesterase-inhibitors-in-alzheimer-disease-and-mixed-dementia-64984https://curecurrent.com/trials/assess-the-prognostic-usefulness-of-flutemetamol-18f-injection-for-identifying-subjects-with-amnestic-mild-cognitive-imp-64985https://curecurrent.com/trials/study-evaluating-single-ascending-doses-of-aab-001-vaccine-sad-japanese-patients-with-alzheimers-disease-64986https://curecurrent.com/trials/a-pilot-study-of-tdcs-for-mild-to-moderate-alzhemier-s-disease-64987https://curecurrent.com/trials/early-diagnosis-of-alzheimer-s-disease-clinical-neuropsychological-and-neuroimaging-follow-up-of-a-cohort-of-patients-wi-64988https://curecurrent.com/trials/performance-of-aclarusdx-a-blood-based-transcriptomic-test-for-ad-in-french-patients-newly-referred-to-a-memory-center-64989https://curecurrent.com/trials/study-of-sta-1-as-an-add-on-treatment-to-donepezil-64990https://curecurrent.com/trials/advance-study-alzheimer-disease-evaluation-in-clinical-practice-64991https://curecurrent.com/trials/pharmacokinetic-interaction-between-azd3480-and-donepezil-64992https://curecurrent.com/trials/escitalopram-for-the-treatment-of-depression-in-alzheimer-s-disease-64993https://curecurrent.com/trials/effect-of-memantine-oral-pump-on-language-in-patients-with-probable-alzheimer-s-disease-64994https://curecurrent.com/trials/delaying-the-progression-of-driving-impairment-in-individuals-with-mild-alzheimer-s-disease-64995https://curecurrent.com/trials/a-study-versus-e2020-10mg-followed-by-an-open-label-extension-phase-to-explore-the-safety-of-e2020-sr-23-mg-in-japanese-64996https://curecurrent.com/trials/normative-values-for-cognitive-testing-and-alzheimer-s-imaging-biomarkers-in-young-adults-64997https://curecurrent.com/trials/a-24-week-efficacy-safety-and-tolerability-of-rivastigmine-patch-study-in-patients-with-probable-alzheimer-s-disease-64998https://curecurrent.com/trials/effectiveness-of-a-brain-computer-interface-based-system-for-cognitive-enhancement-in-the-normal-elderly-64999https://curecurrent.com/trials/phase-ii-study-of-florbetaben-bay-94-9172-pet-imaging-for-detection-exclusion-of-cerebral-amyloid-in-patients-with-proba-65000https://curecurrent.com/trials/oxaloacetate-pharmacokinetics-and-safety-65001